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Summary 
Background:  
     Chondroitin sulfate proteoglycans (CSPGs) constitute a family of extracellular 
matrix molecules that consist primarily of four core proteins (Neurocan, brevican, 
versican, and aggrecan), each of which have varying degrees of associated 
glycosaminoglycans (GAGs) chains, which is mainly chondroitin sulfate (CS). 
Recent advances in research on the metabolism of CSPGs provide the basis for 
exciting new research questions. Controlling and directing the synthesis of CS chains 
to achieve a quick tissue repair is a practical goal. However, careful study of the 
biological function of CS or CSPGs is required before clinical progress can be made 
in wound healing. So far, most of the CS studies focus on the metabolism of CSPGs. 
Compared to the extensive data on the function of heparan sulfate proteoglycans 
(HSPGs), very limited data are available on the exact biological function of CS or 
CSPGs on mammalian cells, expecially on human palatal fibroblasts. Several 
questions need to be answered, such as: 1) Is the expression of CSPGs in palatal 
tissue regulated during wound healing? 2) What is the effect of CS on palatal 
fibroblast activities? 3) What are the roles of specific sulfation pattern of CS on 
palatal fibroblast activities which are related to wound healing?    
Hypothesis:  
    The main hypothesis is that CS is involved in palatal wound healing and regulate 
palatal fibroblast behaviors. To support this hypothesis: (a) The expression of CS 
should change in the in vivo or in vitro wound model. (b) Inhibition of synthesis of 
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chondroitin or sulfation of chondroitin and addition of extraneous CS should affect 
palatal fibroblast biological activities.  
Strategy:  
To examine the above hypotheses, this present study includes a series of five 
experiments in several wound models as follows: 
 Stage1: The roles of CS and its sulfate group in human palatal fibroblast 
adhesion, proliferation, and migration was studied in human palatal 
culture model by addition of inhibitor of sulfation or extraneous CS.  
 Stage 2: The expression of CSPGs, chondroitin sulfate synthases (CHSYs) 
and chondroitin sulfate sulfotransferases (CHSTs) on human palatal 
fibroblasts were evaluated in an in vitro wound model. 
 Stage 3: The importance of CS was evaluated through blocking down the 
expression of CHSY1 by RNA interference (RNAi) in human palatal 
fibroblast culture model.  
 Stage 4: The efficiency of extraneous CS on collagen-fibroblast-gel 
contraction was studied. 
 Stage 5: The expression of CS was investigated in the rabbit palatal wound 
model by monoclonal anti-CS clone CS-56.  
Results:  
This present study included a series of five experiments to investigate the 
biological function of CS and its relationship with palatal wound healing. Stage 1 
experiments examined the roles of CS and its sulfate group in human palatal 
fibroblast adhesion, proliferation, and migration. Inhibition of CS sulfation slows the 
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wound-closure process in vitro. Both chondroitin-4-sulfate (C-4-S) and chondroitin-
6-sulfate (C-6-S) are involved in promoting cell proliferation, an activity that is 
dependent on the presence of the sulfate group. However, the two CS species have 
opposite effects on cell adhesion: chondroitin-6-sulfate increases but chondroitin-4-
sulfate reduces adhesion. Stage 2 experiments illustrated that CSPGs, CHSYs and 
CHSTs had a burst expression at early time after wounding in the in vitro wound 
model. In the stage 3 experiments, blocking down of CS expression by RNAi 
technique resulted in the inhibition of palatal fibroblast proliferation, adhesion and 
migration. Also more cells were arrested in G2/M phase. In the stage 4 experiments, 
extraneous CS efficiently inhibited contraction of collagen-fibroblast-gels. The results 
suggest that CS can suppress contractile activity of palatal fibroblasts. Stage 5 
experiments including in vivo palatal healing in a rabbit model showed that the 
expression of CS56 in the stroma around wound bed increased at early healing stage. 
 
Conclusions:  
In all, these experiments on in vivo and in vitro wound models proved that CS 
and CSPGs are involved in the palatal wound healing; CS affected palatal fibroblast 
cell adhesion, cell proliferation, cell migration and cell cycle; and extraneous CS 
inhibited contraction of collagen-fibroblast-gels. These findings provide a biological 
basis for future application of CS for palatal wound healing. For future clinical 
application, the following studies are needed to focus on these active molecules and 
their correct dosage, timing, sequence of administration, single or combination of 
applications, and efficiency of CS for in vivo wound healing. 
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Chapter I  Literature Review 
1.0.   Introduction 
To achieve a quick and efficient tissue repair is the ultimate goal of wound healing 
research. A common way to accelerate the healing process is to induce the secretion of the 
factors that influence the synthesis of granulation tissue, which fills the wound before 
epithelialization. Early wound healing involves secretion of glycosaminoglycans (GAGs) 
by fibroblasts which form a hydrophilic matrix suitable for remodeling during wound 
healing. The complexity of GAG structure and function in the extracellular matrix (ECM) 
remains poorly studied in wound healing. This literature review is to provide an overview 
of the structure/function of GAGs, especially chondroitin sulfate proteoglycans (CSPGs), 
to understand the biology and current therapy of palatal wound healing. It provides the 
biological and clinical bases for further studies on the structure/function of CSPGs and 
their involvement on palatal wound healing.  
 
1.1. GAGs and PGs  
Connective tissue (CT) consists of several types of cells and extracellular matrix (ECM) 
secreted by some of those cells(see Figure 1.1). ECM is a network of interstitial substances 
secreted by cells which serves as a stuctural support. Unlike other basic tissues (epithelium, 
muscle, nerve), the cells in CT may be widely separated from one another within the 
extracellular matrix. In many types of connective tissues, the matrix-secreting cells are 
called fibroblasts.  
 2
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Connective tissue  
Cells: fibroblasts etc 
ECM:  Fibers: Collagen etc Ground substance: PGs, GAGs, 
Glycoproteins, Tissue fluid, etc 
 
Figure1.1  Principal components of connective tissues. 
 
As illustrated in figure 1, ground substance and fibres are the major components of 
ECM. The ground substance occupies the space between cells and fibres of connective 
tissues. It has a high water content and an amorphous appearance, consisting largely of 
proteoglycans and hyaluronic acid. Proteoglycans are very large macromolecules, 
consisting of a core protein and many GAG molecules which covalently attach  to core 
proteins (see Figure 1.2). The morphology is like the bristles around the stem of a bottle 
brush. 
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Figure 1.2 Structure of the GAG linkage to protein in proteoglycans 
Glycosaminoglycans are sulfated polysaccharides made of repeating disaccharides 
(typically a repeat of 40-100 times), containing hexosamine and hexose (Gal) or hexuronic 
acid (GlcA or IdoA) (see table 1.1). These are the chains whose presence defines a 































































Table 1.1 Nascent Glycosaminoglycan Repeating Disaccharides. 
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The specific GAGs of physiological significance are hyaluronic acid, dermatan sulfate, 
chondroitin sulfate, heparin, heparan sulfate, and keratan sulfate (shown in Table 1.2) 
(Iozzo et al., 1996, Yanagishita et al., 1992). The type of disaccharide unit endow GAGs 
with unique functions as chondroitin or dermatan sulfate (GalNAcβ1-4GlcA/IdoA), 
heparin or heparan sulfate (GlcNAcα1-4GlcA/IdoA), or keratan sulfate (Galβ1-4GlcNAc). 
Keratan sulfate is actually a 6-O-sulfated form of a polylactosamine and is therefore 
attached to an N- or O-glycan core rather than a typical proteoglycan core region.  
The glycosaminoglycans (except for hyaluronan) also typically have sulfate esters 
substituting either hydroxyl or amino groups (N- or O-sulfate groups). Sulfation of 
glycosaminoglycans in chondroitin sulfate chains is usually regular, one sulfate per 
disaccharide throughout the chain, while in heparan sulfate chains, sulfation is somewhat 
irregular, and resulting in intensely sulfated and sparsely sulfated regions on a single 
glycosaminoglycan chain.  
Hyaluronic acid is unique among the GAGs in that it does not contain any sulfate 
group and is not found covalently attached to proteins as a proteoglycan. It is, however, a 
component of non-covalently formed complexes with proteoglycans in the ECM. 
Hyaluronic acid polymers are very large (with molecular weights of 100,000 - 10,000,000) 
and can displace a large volume of water. This property makes them excellent lubricators 
and shock absorbers.  
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Heparin/Heparan sulfate 
GlcN and GlcUA or IdUA 
N and O sulfate (C2,3,6) 






Sulfate at 4 or 6 C of GalNAc 
b-1,3 glycosidic linkage  
Dermatan sulfate: 
IdUA with some GlcUA 
Sulfate at 4 or 6 C of GalNAc 
b-1,3 glycosidic linkage 
 
Keratan Sulfate: 
Type I: GlcNAc and Gal (no 
UA) 
Sulfate on C6 of Gal or HexN 
b-1,4 glycosidic linkage  
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Hyaluronan (unsulfated): 
No protein link 
No sulfate 






















Table 1.2 Structure of hyaluronic acid, dermatan sulfate, chondroitin sulfate, heparin, 
heparan sulfate, and keratan sulfate 
      Proteoglycans (PGs) are a class of glycosylated proteins which are present in almost all 
cell types where they can be found in soluble forms, in the extracellular matrix (ECM), 
associated with plasma membrane, or segregated into intracellular granules. PGs can also 
be classified on the basis of their localization and on the type of the core protein (as table 
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Localization GAG-chain Mr of the core 
protein (kD) 
Principal members 
ECM HA, CS, KS 225-250  aggrecan, versican 




HS 120 perlecan 





heparin, CS  17-19 serglycin 
Table 1.3  Classification of proteoglycans on the basis of their localization and type of core 
protein  
(CS, chondroitin sulfate; DS, dermatan sulfate; KS, keratan sulfate; HA, hyaluronic acid; 
HS, heparan sulfate ) 
     In recent years, studies about GAGs and PGs have increased dramatically leading to 
better comprehension of their biosynthesis and structure, together with the demonstration 
of the involvement of GAGs and PGs in various physiological processes. The biological 
functions of GAGs and PGs are highly diversified, ranging from relatively simple 
mechanical support functions to more intricate effects on various cellular processes such as 
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cell adhesion, proliferation and differentiation. Other effects are due to the ability of PGs to 
act as "receptors" for adhesion molecules and circulating molecules such as growth factors, 
cytokines, and a variety of enzymes including proteases and coagulation enzymes. The 
other parts of these effects are due to GAG-chains. GAGs are highly negatively charged 
molecules, with extended conformation that imparts high viscosity to the solution. GAGs 
are located primarily on the surface of cells or in the extracellular matrix (ECM). Along 
with the high viscosity of GAGs comes low compressibility, which makes these molecules 
ideal for a lubricating fluid in the joints. At the same time, their rigidity provides structural 
integrity to cells and provides passageways between cells, allowing for cell migration. 
 
1.2. Chondrointin sulfate PGs 
CSPGs consist of a protein core and long, unbranched polysaccharides 
glycosaminoglycans (GAGs) comprising CS disaccharide unit repeats. The core proteins 
known to bear mainly CS GAGs are hyalectans (including brevican, neurocan, versican, 
aggrecan, NG2, phosphacan, appican, decorin, biglycan and neuroglycan C (Bandtlow et 
al., 2000).  
        Proteoglycans can be divided into aggregating and nonaggregating PGs. The key 
features that distinguish between these two groups are their ability or inability to aggregate 
with HA and the number of GAG side chains bound to the protein core.  Aggrecan is the 
best-known and best-understood aggregating PG (see Figure 1.3). A large compliment of 
CS chains (approximately 100) and a smaller compliment of KS chains (approximately 30) 
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are attached to the protein core. As the GAG chains attached to the PG core are negatively 
charged, they extend from the core protein like the bristles of a bottle brush and create high 
charge density. This charge density induces an osmotic swelling pressure which result in 
the movement of water into the matrix (Heinegard et al., 1993; Hardingham et al., 1992; 








The nonaggregating PGs do not bond to HA and frequently possess only a small 
number of GAG side chains composed of CS and DS. They appear to play a limited role in 
withstanding compression, but they interact with other matrix components and contribute 
to mechanical stability through interaction with collagen. Decorin, which has one GAG 
chain, is one of the smallest PGs and functions, in part, to link adjacent collagen fibrils. 
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Biglycan (2 GAG chains) is also small and is found in the matrix between bundles of 
collagen fibrils (see Fig 4). The mechanical and other functions of biglycan are not 
understood, but both biglycan and decorin play a role in regulating cell activity, most 
notably through the binding of growth factors through specific high- and low-affinity sites 
on the core proteins. (Hardingham et al., 1993; Bianco et al., 1993). 
  
Figure 1.4  Representation of biglycan (2 glycosaminoglycan side chains) and decorin (1 
chain), with their similar core proteins. CS=chondroitin sulphate, DS=dermatan sulphate, 
S-S=disulphide bonds, Y=oligosaccharides. (Heinegard et al.,1993). 
 
In addition to the different type of core proteins of CSPGs, six different CS 
disaccharide units can form the GAGs. Each of these carries one or two sulphate groups in 
different positions depending on the presence and the activity of different chondroitin 
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sulphotransferases (CSSTs), the enzymes responsible for the sulphation of GAGs, in the 
Golgi apparatus. Along the sugar chains, the presence of different disaccharide units results 
in the formation of specific structural motifs known as CS-A, CS-C, CS-B and CS-E. The 
sulphation pattern of each of these units influences the binding properties of the GAGs and 
thus the overall function of the CSPGs (Kinoshita et al., 2001).  
Chondroitin sulfate PGs (CSPGs) have been demonstrated to be involved in wound 
healing procedure, suggesting that the study of the structural and biochemical bases of 
CSPG function may help to understand and improve wound repair.  
 
1.2.1. Structure of CS 
 
      CS consists of repeating sulfated disaccharides containing N-acetygalactosamine. The 
CS chains, incorporating both oversulfated and non-sulfated structures, have been roughly 
classified into types A, C, D, E, K and H (Sugahara K, Yamada S, 2000). It is named as 
chondroitin sulfate A (GlcAβ1-3GalNAc(4S), C-4-S), chondroitin sulfate C (GlcAβ1-
3GalNAc(6S), C-6-S),  chondroitin sulphate D (GlcA(2S) β1-3GalNAc(6S), C-2,6-S), 
chondroitin sulfate E (GlcAβ1-3GalNAc(4S,6S), C-4,6-S),  chondroitin K (GlcA(3S) β1-
3GalNAc(4S), C-3,4-S) and chondroitin sulfate H (IdoAα1-3GalNAc(4S,6S) ), where 4S 
and 6S represent 4-O and 6-O-sulfate respectively (see Figure 1.5). Degrees of sulfation, 
and ratios of C4S to C6S are highly variable between individuals and tissues.  
 13
Chapter I  Literature Review 
 
       
 
   




Chapter I  Literature Review 
1.2.2. Biosynthesis of CS 
 
      The steps in the assembly of proteoglycans are: 1). Synthesis of the core protein, 2) 
xylosylation of specific serine moieties of the core protein in the endoplasmic reticulum 
and/or early Golgi, 3) sequential addition of two galactose (Gal) residues to the xylose 
(Xyl) in early Golgi, 4) sequential addition in later Golgi fractions of GlcA and GalNAc to 
complete a GalNAc-GlcA-Gal-Gal-Xyl pentasaccharide linkage region, 5) addition of the 
repeating disaccharide units consisting of alternating GlcA and GalNAc, 6) modification of 
the growing polymer by sulfation of the GalNAc at the 4 or 6 position, 7) epimerization of 
varying amounts of GlcA to IdcA in the case of dermatan sulfate, 8) 2-sulfation of some 
IdcAor GlcA(Linhardt et al.,995) 
Polymerization to form glycosaminoglycans takes place on the nascent proteoglycan 
with UDP-GlcA and UDP-GalNAc as precursors (Silbert et al., 1997) The nascent 
proteoglycan appears to remain attached to Golgi membranes during the entire process of 
assembly with channeling between individual membranes-bound enzymes to form the Gal-
Gal-Xyl linkage and then to what appears to be membrane-bound enzyme complexes to 
complete the GalNAc-GlcA-Gal-Gal-Xyl linkage together with glycosaminglucan 
polymerization, sulfation, and epimerization.(Silbert et al., 1995) 
       Sulfation of chondrotin takes place while the polymer is formed with the same Golgi 
subfractions that have polymerization activity (Sugumaran et al., 1990, 1991) .These 
subfractionation studies and experiments on the effects of the ionophore monensin on 
dermatan sulfate synthesis have suggested that sulfation occurs in medial, trans, or 
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medial/trans Golgi network. Consequently, 4-sulfation and 6 sulfation enzymes must be 
co-localized with the enzymes of polymerization. The chondrotin polymer is modified to 
form dermatan sulfate by transfer of sulfate from adenosine 3’-phosphoadenylyl 5’-
phosphosulfate (PAPS). Epimerization being found only where there is 4-sulfation, 
demonstrating that this enzyme is colocalized with the enzymes of polymerization and 4-
sulfation (Silbert et al., 1986; Hoppe et al., 1985). 
       Synthesis of the core protein with its transport to sites for glycosaminoglycan 
formation appear to be the sole controlling factor in the formation of the proteoglycans 
under ordinary conditions. This has been demonstrated by the manifold increase in 
formation of fully formed glycosaminoglycans that have been found when β-xylosides 
were added to many different culture systems, presenting an artificial substrate for step3 
through 8 of the assembly of proteoglycans. Consequently, cultured cells, and presumably 
cells in vivo, are ordinarily able to provide ample excess substrates and enzymes for a 
massive increase in production. Exceptions to this only appear to occur in situations in 
which there is a deficit in a particular enzyme or substrate brought about by one or another 
mutation. Thus, cells that lack full capacity to transport sulfate have diminished sulfation 
(Esko et al., 1986; Rossi et al., 1996) and cells lacking a specific glycosyl transferase 
(Lidholt et al., 1992), specific sulfatransferase(Bai et al.,  1996), or with a deficiency of an 
enzyme for transport or formation of a particular substrate, such as UDP-Gal or 
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1.2.3. Functions of CS 
 
Chondroitin and chondroitin sulfate, are widely distributed as glycosaminoglycan 
sidechains of proteoglycans in the extracellular matrix and at cell surfaces. Despite their 
wide distribution and common synthetic pathway to HS, CS has attracted less attention 
than HS.   
Generally, biological functions of proteoglycans derive primarily from those of the 
glycosaminoglycan and protein component of the molecule. Glycosaminoglycans assume 
extended structures in aqueous solutions because of their strong hydrophilic nature based 
on their extensive sulfation, which is further exaggerated when they are covalently linked 
to core proteins. They hold a large number of water molecules in their molecular domain 
and occupy enormous hydrodynamic space in solution. Another remarkable property of the 
glycosaminoglycans is their capability to specifically interact with a number of important 
growth factors and functional proteins. Such interactions are often crucial to the biological 
functions of these proteins. Properties of core proteins are also exerted through interactions 
with other molecules, especially when proteoglycans are involved in the formation of 
extracellular matrix.  Cell surface proteoglycans such as the syndecans and glypicans, 
generally function by the interation with matrix or other cells or as receptors or facilitators 
for extracellular substances (Silbert et al., 1997). For example, syndecan-1 has been 
implicated in attachment of epithelial cells to matrix by interacting both with matix 
substances such as fibronectin and with the actin cytoskeleton (Bernfield M, Sanderson RD, 
1990).                
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General glycosaminoglycan functional characteristics relate to length of chains, 
degree of charge on individual polysaccharide chains, and density of charge provided by 
number of chains. In this fashion, versincan, the large matrix proteoglycan (10-20 
chondrotin sulfate chains) of skin as well as other tissues, functions in salt and water 
balance, as a macromoleculear filter, and as a cushion to physical pressures. The highly 
polyanionic structure controls a large domain, so that a volume of water many times the 
volume of the proteoglycan itself can be contained within the external limits of the 
molecule. In this domain, small noncharged molecules move freely, but large molecules, 
such as proteins, are excluded by the nature of the highly charged GAGs chains. Under 
pressure, some of the water can be expressed from domain, and with release of pressure the 
water reoccupies the space. Together with hyaluronan which has a high viscosity in dilute 
solution, versican helps to provid support for other components of tissues (Kinsella et al., 
2004). 
As for CSPGS, chondroitin/dermatan sulfate proteoglycans are widely distributed 
within the interstitial matrix, where they are known to bind a variety of both soluble and 
insoluble ligands. The effects of these proteoglycans on the formation of the ECM and the 
response of cells to growth factors and cytokines both directly and indirectly influence 
cellular proliferation, migration, and phenotype.  
         Susceptibility to degradation is an additional functional consideration for CS GAGs 
microstructure, since variable stability and turnover of GAGs may depend upon their 
susceptibility to enzymatic degradation. Thus, the detailed positions and degrees of 
epimerization, sulfation, and stability of GAGs provide multiple specificities for function, 
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including potential effects upon wound healing. It is possible that modifications of 
chondroitin sulfate, possibly affecting the quality of healing, could be achieved by the 
simple, easy procedure of the availability of sulfate. The key to this lies in the high 
concentrations of sulfate necessary for full epimerization and sulfation during biosynthesis 
in vivo, the order in which specific sulfate residues are affected, and the variability among 
individuals concerning dietary sulfate and the capacity for skin or other tissues to produce 
sulfate from sulfhydryl-containing amino acids. Modification in the availability of sulfate 
would not likely be of practical use for affecting heparin sulfation since full sulfation can 
occur at much lower concentrations than the high sulfations required for chondrotin 
sulfation. 
       
1.2.3.1 CS and cell proliferation 
 
       Growing evidence suggests that CS chains have intriguing functions in wound repair,  
growth factor signaling and cell division. Syrokou et al., (1999) found that chondroitin 
sulphates (CSs) and dermatan sulphate (DS) strongly stimulate the proliferation of 
fibroblast-like cells in a dose-dependent manner (170-250% at 100 microg/ml), 
independently of their sulphation pattern. In epithelial cells, however, only DS stimulates 
cell proliferation. The effects of CSs on proliferation of epithelial cells are not dependent 
on their sulphation pattern. Thus, CSs either with -[GlcA-GalNAc-(-6-O-SO(3)-)]- or -
[GlcA-GalNAc-(-4-O-SO(3)-]- as the commonest unit, had no significant different effect.  
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Studies have shown that CS and dermatan sulfate are able to bind to fibroblast growth 
factor-2 (FGF-2) and initiate cell proliferation (Penc et al., 1998). FGF-2 is an important 
growth factor in regulating cell proliferation (Rikin et al., 1989). It has been shown to 
stimulate proliferation of keratinocytes from gingival tissue in vitro (Fujisawa et al., 2002). 
Binding of CS to FGF-2 initiate the binding FGF-2 to its receptors. This binding results in 
dimerization and tyrosine phosphorylation of these receptors which eventually initiates the 
downstream cascade that causes cell proliferation (Bernfield, et al., 1999). 
 
1.2.3.2 CS and cell adhesion 
 
CD44 is a widely expressed cell adhesion molecule that binds the extracellular matrix 
component, hyaluronan, in a tightly regulated manner. Previous studies have shown that 
the CD44-hyaluronan interaction is affected by changes in the glycosylation state of CD44. 
(Esford et al., 1998.). It was also reported that sulfation and, in particular, the addition of 
chondroitin sulfate are required for inducible hyaluronan binding by CD44 in murine L 
cells. However, in the absence of fully processed oligosaccharides, chondroitin sulfate is 
not essential for hyaluronan binding, indicating that the adherent effect of chondroitin 
sulfate is dependent upon the glycosylation state of the cell. Thus, in addition to 
glycosylation, chondroitin sulfate biosynthesis is an important post-translational 
modification that can affect the hyaluronan binding ability of CD44. 
A CS binding site has been reported in α4β1 integrin (Iida et al., 1998). Thus, CS 
binds to α4β1 integrin and enchances integrin-mediated cell adhesion, FAK 
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phosphorylation and activation of ERK pathway. Integrins are a family of heterodimeric 
adhesion receptors that mediate both cell-cell and cell-extracellular matrix adhesion. 
Integrins intiate multiple cellular signals that profoundly influence shape proliferation, 
differentiation, invasion, metastasis, apoptosis, and anoikis (Dedhar et al., 1999; Juliano et 
al., 2002). Integrin-mediated cell adhesion activates a major nonreceptor tyrosine kinase, 
focal adhesion kinase (FAK). FAK serves to integrate signaling pathways between growth 
factor receptors and integrins (Sieg et al., 2000) and is implicated in facilitating cell 
survival and regulating cell spreading, migration and invasion (Hauck et al., 2002). 
Autophosphorylation of FAK can lead to stimulation of a cell-signalling cascade that 
ultimately activates the RAS/MAPK extracellular signal-regulated kinase (ERK) pathway 
(Sieg et al., 2000). ERK is a major effector of cell migration, growth and survival (Howe et 
al., 2002). 
 
1.2.3.3 CS and cell migatrion      
Studies have shown that RhoA inhibition is involved in cell migration (Cox EA, et al., 
2001). A high RhoA activity level inhibits cell migration (Arthur WT, Burridge K, 2001). 
It was reported that FAK is necessary for the initial RhoA inactivation (Ren XD, et al., 
2000). CS enchances cell spreading and migration by activating FAK phosphorylation and 
phosphorylated FAK inhibits RhoA (Yang J, et al., 2004).  
Henke CA et al (1996) examined whether cell surface CSPG can mediate similar 
events in nonmalignant wound microvascular endothelial cells or whether use of CSPG for 
migration and invasion is a property largely restricted to malignant cells. Their findings 
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suggest that CD44-related CSPG is capable of binding fibrinogen/fibrin, thereby mediating 
endothelial cell migration and invasion into the fibrin provisional matrix during wound 
repair. Similarly, Clark RA (2004) demonstrated that dermatan/chondoitin sulfate-CD44H 
proteoglycan is essential for fibroblast migration into fibrin clots and that platelet-derived 
growth factor, the stimulus for migration, induces the production of chondroitin-sulfate- 
and dermatan-sulfate-glycanated CD44H. 
 
1.2.3.4 CS and cell division and cytokinesis 
    In addition to their conventional structural roles (Sugahara K, et al., 2003), the 
novel functions of chondroitin in the morphogenesis and cell division were recently 
revealed. Recent studies by Mizuguchi S ,et al (2003)  revealed that chondroitin is essential 
in cytokinesis and morphogenesis in early embryonic stages of Caenorhabditis elegans (C. 
elegans). Nonsulfated chondroitin is indispensable in the morphogenesis and cell division 
of C. elegans, as revealed by RNA interference experiments of the recently cloned 
chondroitin synthase gene and by analysis of mutants of squashed vulva genes. 
 
 
1.3. Experimental methods for CS function study 
 
1.3.1 Production of undersulfated chondrotin sulfate 
        With the exception of hyaluronic acid, all glycosaminoglycans are highly sulfated. In 
the process of GAG sulfation, 3'-phosphoadenosine-5'-phosphosulfate (PAPS) serves as a 
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sulfate donor and is catalyzed by ATP sulfurylase and APS kinase, activities that reside on 
a single bifunctional protein in mammals. If PAPS cannot be synthesized, these biological 
sulfation reactions will not proceed. Chlorate is a competitive inhibitor of PAPS synthesis 
and, as such, can block sulfation reactions. 
        Undersulfation of proteoglycans can easily be produced in vitro with explants or 
cultures of cells by restricting sulfate in the growth media (Humphries et al., 1989; Sibert 
et al., 1993) or in cells by using chlorate (Greve et al., 1988) to block the formation of 
PAPS. The former technique is limited by the capacity of some cells to produce their own 
sulfate from cysteine or methionine (Humphries et al., 1988), while the latter technique 
will eliminate sulfation to various degrees depending on the concentration of chlorate. 
          The advantages of using low sulfate concentrations for undersulfation are the lesser 
likelihood of disturbing other aspects of cell metabolism. However, some cells (Esko et al., 
1986; Humphries et al., 1988), including skin fibroblasts from some but not all individuals 
(Silbert et al., 1991) are capable of making their own sulfate from cysteine or methionine 
so that sulfate in the growth media would not be needed to obtain sulfation. Even though 
no major changes in a 24 hour incubation of skin fibroblasts under these conditions were 
seen, there could well have been an effect upon the production of matrix over a longer time 
period. 
Previous studies reduced the sulfation of chondrotin in skin fibroblast cultures to as 
low as 20% by reducing culture medium sulfate concentrations to 0.01 mM (Silbert et al., 
1986) and in endothelial cells to less than 2% by use of 30 mM chlorate (Humpries et al., 
1988). However some small effects on sulfation were seen even at concentrations as low as 
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0.2 mM (Silbert et al., 1986). Undersulfation of chondrotin by incubations in low sulfate or 
with chlorate resulted in undersulfated GAG chains with random or near random 
distribution of the unsulfated residues (Silbert et al., 1986; Silbert et al., 1993).  
Normal serum sulfate concentrations in human have been reported to range from 
approximately 0.2 to 0.4 mM (Edwards et al.,  1993; Morris et al., 1990), overlapping the 
range where undersulfation chondrotin can begin. This is in contrast to sulfate  
concentrations in other animals, such as mice and rats, which have serum levels as high as  
1.2 mM (de Vries et al., 1985) . As might be expected , ingesting drugs that are conjugated 
with sulfate (salicylates, acetaminophen, paracetamol) have the effect of lowering serum 
sulfate (van der Kraan et al., 1988) , and even have been reported lowering as much as 
75%  after intraperitoneal injection of salicylate into mice (de Vries et al., 1985) . Reduced 
incorporation of sulfate into proteoglycans has been seen with cultured cartilage explants 
from a number of animals (van der Kraan et al., 1989), but only with human cartilage 
explants was there an effect within the physiological range of sulfate concertration (van der 
Kraan et al., 1990). Diminishing of sulfation by as much as one-third was seen when 
medium sulfate concentration was lowered from 0.3 to 0.2 mM. It should be noted that 
cartilage cells require an extracellular source of sulfate in order to produce their large 
amount of proteoglycans, since chondrocytes appear to be incapable of obtaining sulfate by 
metabolism form cyteine or methionine. Therefore, cartilage should be the most sensitive 
tissue to sulfate depletion.  
        In comparison to restricting sulfate in the growth media, the use of chlorate to 
produce undersulfated PGs is easier to control and reproduce. Cell grown in the presence 
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of chlorate, even at concentrations high enough to eliminate cell sulfation, are surprisingly 
healthy, with little limitation in growth or subculturing. This has the advantage of 
examining the biosynthesis under conditions of limited sulfation even while serum is 
present in the culture medium. However, there is always the possibility that observed 
changes in cell function, metabolism, interaction, etc could be due to effects of chlorate on 
cell growth or metabolism other than directly blocking sulfation. 
       So far, there has not been much attention given to the mechanism by which 
undersulfation might affect cell/tissue structure and bioactivity, and tissues other than skin 
and cartilage have not been examined to any extent for decreased sulfation. 
 
 
1.3.2 Potential effects of undersulfation of CS on cell function  
    
Chondroitin sulfate has been implicated in the signaling functions of various heparin-
binding growth factors and chemokines. These functions are closely associated with the 
sulfation patterns of the glycosaminoglycan chains. 
Effects of undersulfation on specific actions of cell surface proteoglycans might be of 
considerable importance (Penc et al., 1998). It was determined that the small 
proteodermatan/chondrotin sulfate in skin tendon and conea is decorin, and that it occupies 
up to four binding sites in each D period of the α 1 chain of type I collagen fibrils through 
the attachment of a horseshoe-shaped decorin core protein (Scott et al., 1996; Webert et al., 
1996). Recently, the role of decorin in skin collagen fibril morphology has been confirmed 
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directly by electron microscopic examination of skin from a spontaneously aborted decorin 
deficent human fetus (Scott et al., 1998) and skin from decorin null mice (Danielson et al., 
1997) These clearly demonstrated a loss of the glyconsaminoglycan bridging between 
collagen fibrils which was accompanied by marked skin fragility.  
       Since disruption in maintenance of collagen fibril placement might be expected to 
modify shape and destabilize the ECM, any defect in chondrotin /dermatan formation 
resulting in a decrease of fibril-to-fibril stability might affect connective tissue to a 
considerable degree. Degradation or destabilization of matrix due to lower sulfation may 
be highly relevant in wound healing. Thus, modification in sulfation levels of PGs might 
be of considerable significance for wound repair. 
 
1.3.3 Blocking CS related gene  by RNAi  
 
Synthetic small interfering RNA (siRNA) describes the use of exogenous RNA to 
interfere with the function of an endogenous gene.  siRNA technology grew out of early 
attempts to use antisense-mediated genetic interference as a tool to study gene function 
(Guo et al., 1995).  It is a powerful tool for modulating gene expression in cell culture. The 
effects of siRNA are mediated by a conserved cellular RNAi pathway (Denli et al., 2003). 
In 2001, Elbashir demonstrated sequence-specific repression of target-gene expression 
using synthetic siRNA duplexes in mammalian cells (Elbashir et al., 2001), resulting in 
rapid adoption of the technology by researchers. The usefulness of siRNA as a laboratory 
tool and for target validation is clear with more than 800 publications citing use of siRNA 
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since 2002. This remarkable success has led to high expectations for siRNA as a research 
and therapeutic platform. 
Very recently, the novel function of CS was revealed by using RNAi. Mizuguchi et al 
(2003) treated C. elegans with ChSy dsRNA and first detected phenotypic abnormalities in 
P0 worms 12 h after introducing the RNAi.  The results revealed that fertilized eggs laid 
within 11–12 hours of RNAi treatment could not complete cell division, particularly 
cytokinesis. It suggested that chondroitin on the embryonic cell surface is necessary to 
complete cell division, particularly cytokinesis, and has a crucial role in embryonic 
development (Mizuguchi et al., 2003). 
The advantages of the RNAi technique and the surprising function of chondoitin 
warrant further investigations to bring insights into the biological function of CS, 
especially in the human cells/tissues. Any findings in this field might help understand 
wound healing and find new therapies. 
 
1.4. Wound healing 
Wound healing is a complex and dynamic process of restoring cellular structures and 
tissue layers. The capacity of a wound to heal depends in part on its depth, as well as on 
the overall health and nutritional status of the individual. According to the pathology and 
physiology of wound healing, human adult wound healing process can be divided into 3 
distinct phases: the inflammatory phase, the proliferative phase, and the remodeling phase. 
A complex and coordinated series of events happen during adult wound healing. They 
includes chemotaxis, phagocytosis, neocollagenesis, collagen degradation, collagen 
 27
Chapter I  Literature Review 
remodeling, angiogenesis, epithelization, and the production of new glycosaminoglycans 
(GAGs) and proteoglycans. The culmination of these biological processes results in the 
replacement of normal connective structures with fibroblastic scar tissue (Aukhil I, 2000). 
1.4.1 Wound healing model 
Wounds are heterogeneous and wound healing process is influenced by many 
externally introduced factors and compounds. In order to obtain new knowledge of the 
complexity of this process, a model is needed to clarify thinking, assist in the generation of 
hypotheses, and simplify complex problems (Gottrup et al., 1998). Wound models can be 
divided into in vitro and in vivo models. 
In vitro test systems can be as simple as single-cell systems or be as complex as 
multicellular systems in artificial three-dimensional (3-D) matrices. In all systems it is 
possible to study the cellular functions of migration, proliferation, protein synthesis and 
wound contraction ( Tarnuzzer et al., 1996; Danielsen et al., 1998).  
       The in vitro wound healing models has a major advantage. It can directly examine the 
effect of an environmental change or substance on the tissue without influencing other 
tissue components. However, it has the difficulty in extrapolating results to the wounded 
tissue in an otherwise normal organism ( Gottrup et al., 1998).  
In vivo models can be animal or human models. Their advantages are that wounded 
tissue is similar to wounds found in the clinical practice. The disadvantages are that direct 
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examination of single tissue components are difficult, and there may be an ethical problem 
(Gottrup et al., 1998; Gottrup et al., 1999).  
How to chose experimental model depends upon the problem itself, but also upon 
some important practical factors such as the space and physical facilities, laboratory 
facilities, technical expertise, financial resources, time, and ethical and legal factors. But 
the most important factor is  the type of parameters relevant to describe the raised problem. 
In this study, in vivo animal wound healing model and in vitro human monolayer cell 
or 3-D multi-human-cellular wound healing models are used for investigating the 
expression and function of CS in palatal wound healing according to particular objectives 
of each experiment. 
 
1.4.2 CS in wound repair 
 
There have been no significant studies regarding the relationship of sulfate 
metabolism or specific glycosaminoglycan sulfate fine structure to wound healing. 
However, it is clear that chondrotin sulfate proteoglycans are important factors in healing, 
and that their structures can be modified greatly under conditions of low sulfate availability. 
Moreover, effects of undersulfation of chondroitin sulfate proteoglycans produced by 
human skin fibroblasts in culture have been shown to be highly variable (Silbert et al., 
1991). Thus fibroblasts from some individuals are capable of synthesizing as much sulfate 
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as necessary from cysteine and /or methionine, while fibroblasts from others are not. 
Sulfate in human is derived directly by ingestion of sulfate-containing substances, but 
metabolism (mainly in the liver) of dietary sulfhydryl-containing amino acids is the main 
source. A decrease in the capacity of liver to produce sulfate, or any protein deficiency, 
could easily lead to undersulfation if dietary sulfate is low. Should this occur, one might 
find that the simple expedient of providing supplementary sulfate could protect against 
inadequate wound healing due to inadequate sulfation. This could be accomplished by 
increased sulfate intake or even by local administration. It would be of particular 
importance for those individuals whose skin lacked the capacity for forming sulfate from 
sulfhydryl-containing amino acids. 
 
Gilbert et al. (2004) compared the wound healing properties of CS hydrogel versus no 
treatment in wounds of New Zealand white rabbit maxillary sinus mucosa. It was found 
that CS hydrogel accelerated wound healing in sinonasal mucosa at a 4-day endpoint. The 
findings implicated that the CS hydrogel acts as a surrogate extracellular matrix, serving as 
a repository for cytokines and growth factors produced by the regenerating mucosa. It may 
also provide a structural framework for fibroblasts and epithelial regeneration.  
 
1.5 Palatal development  
The embryonic development of the palate can be divided into two separate phases: 
formation of the primary palate followed by formation of the secondary palate. Human 
palatal development begins at approximately day 35 of gestation with the emergence of 
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facial processes. Formation of the primary palate includes the fusion of the medial nasal 
process (MNP) with the maxillary process (MxP), followed by the lateral nasal process 
(LNP) with the MNP,. Failure of fusion or breakdown of fusion of the processes results in 
a cleft of the primary palate. Formation of the secondary palate begins at the completion of 
primary palate formation. The secondary palate arises from the bilateral shelves that 
develop from the medial aspect of the MxP. The two shelves meet in the midline with 
elevation of the shelves. As the shelves move superiorly, the fusion process begins. 
Interference with the fusion leads to clefting of the secondary palate (Johnston et al., 1990). 
The incidence of cleft lip/palate by race is 2.1/1000 in Asians, 1/1000 in whites, and 
0.41/1000 in blacks. Isolated cleft palate shows a relatively constant ratio of 0.45-0.5/1000 
births. The pathologic sequelae of cleft palate include feeding and nutritional difficulties, 
recurrent ear infections, hearing loss, abnormal speech development, and facial growth 
distortion. In the last 40 years, great progress has been made toward a better understanding 
of many aspects of cleft lip and palate defect, but there is still a long way to go before there 
is agreement on the optimal treatment procedures. (Kaufman et al., 1991). 
 
1.6  CS in Palatal development  
The expression of proteoglycans detected by the monoclonal antibodies MO-225, 3B3 
and 2B6 and of peanut agglutinin-binding molecules was examined histochemically during 
the development of bovine palatine ridge (PR) rudiments in fetuses with crown-rump 
lengths of 4-60 cm. The bovine PR rudiment has two characteristic developmental stages: 
the first is the positioning of the epithelial placode (EP) to the predetermined site of PR 
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rudiment formation and the second is the reorientation of the apical edge of PR rudiments 
to form wave-like patterns from mouth to pharynx. During the 1st stage, chondroitin 6-
sulphate (C-6-S) is expressed strongly at the epithelial basement membrane just beneath 
the EP. During the 2nd stage, both C-6-S and the disaccharide unit Glc2sulphate-
GalNAc6sulphate (GlcA2SO4-GalNAc6SO4) were distributed at the basement membrane 
and the mesenchyme just beneath the steeper wall of the PR rudiment. Peanut agglutinin-
binding molecules were also detected in the mesenchyme, their distribution being similar 
to that for C-6-S and GlcA2SO4-GalNAc6SO4, and additionally in the epithelial cells after 
formation of the wave-like PR. The results suggest that 2 different types of proteoglycan 
may be involved in the critical periods during the morphogenesis of the bovine PR 
rudiments (Takanosu et al., 1996).  
 
In mammals, adhesion and fusion of the palatal shelves are essential mechanisms in 
development of the secondary palate. Failure of any of these processes leads to the 
formation of cleft palate. The mechanisms underlying palatal shelf adhesion are poorly 
understood, although the presence of filopodia on the apical surfaces of the superficial 
medial edge epithelial (MEE) cells seems to play an important role in the adhesion of the 
opposing MEE. They demonstrate here the appearance of chondroitin sulphate 
proteoglycan (CSPG) on the apical surface of MEE cells only immediately prior to contact 
between the palatal shelves. This apical CSPG has a functional role in palatal shelf 
adhesion, as either the alteration of CSPG synthesis by beta-D-Xyloside or its specific 
digestion by chondroitinase AC strikingly alters the in vitro adhesion of palatal shelves. 
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They also demonstrate that the expression of CSPG on the apical surface of MEE cells is a 
key factor in palatal shelf adhesion and that this expression is regulated by TGF-beta (Gato 
et al., 2002). 
 
1.7 Palatal wound healing 
The goal of the main indication for cleft palate treatment are to separate the oral and 
nasal cavities by repairing the oral and nasal mucosa and repositioning the soft palate 
musculature to anatomically recreate the palate to establish normal speech (Ross et al., 
1987) Cleft palate surgery in young patients is considered to be one of the factors causing 
disturbances in maxillary growth and dento-alveolar development (Kremenak et al., 1984). 
The adverse effects of surgery have been attributed to wound contraction and scarring in 
the remaining palatal wound (Wijdeveld et al., 1991; Ishikawa et al.,  1998; Ehrlich et al.,  
1996). The connection of scar tissue to palatal bone by Sharpey's fibers might lead to 
maxillary growth inhibition   (Leenstra et al.,  1995). 
Since scar tissue presents many problems, for instance, impairment of growth, the 
reduction or prevention of scar formation has long been a desirable goal. Recent 
developments in surgery and basic science research offer surgeons the prospect of scarless 
repair (Molsted et al., 1999). It appears that there are considerable possibilities for the 
reduction of human scarring after surgery with the introduction of various wound-healing 
medications promoting wound healing (Chang et al., 1995).  
Collagen, GAGs and elastic fibers determine the mechanical properties of soft 
connective tissues. Crucial differences between scar tissue and normal tissue are related to 
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these components. Therefore, changes in collagen, glycosaminoglycans and elastic fibers 
have to be studied in order to understand the mucoperiosteal healing process. This may 
offer new prospects for improving the clinical outcome of palatal surgery. It is reported 
that the number of collagen type I and type III fibers gradually increased until about 8 days 
postwounding, and thereafter the staining intensity of collagen type III decreased. At 60 
days post-wounding there were more transversely oriented collagen type I fibers and less 
type III fibers and elastin present in the submucosa than in normal tissue (Cornelissen AM, 
et al., 2000). Besides collagens, study on expression of GAGs such as CS during palatal 
wound healing also need to be carried out and may offer new prospects for improving the 
clinical outcome of palatal surgery. 
 
1.8 Conclusions 
The rapidly accumulating evidence reviewed here strongly suggests that chondroitin 
and CS chains have crucial biological functions in wound repair and cell activities. 
However, the evidence is fragmentary and immature, and no research has been carried out 
on the function of CS on palatal wound healing. So studies of CS on palatal fibroblasts 
culture model will help understand the possible roles of CS on palatal wound healing and 
reveal the molecular mechanisms underlying these functions. The knowledge obtained 
from such analyses will provide evidence for further application of CSPG to improve 
palatal wound healing. 
 34













Chapter II  Hypothesis and objectives 
Hypothesis: The main hypothesis is that CS is involved in palatal wound healing and 
regulates palatal fibroblast behavior. To support this hypothesis: (a) Inhibition of CS 
or addition of extraneous CS should affect palatal fibroblast biological activities. (b) 
The expression of CS should have some changes in the in vivo or in vitro wound 
model. 
 
Methods: To test the above hypotheses, five experiments were carried out in several 
wound models as follows: 
 Stage1: The roles of CS and its sulfate group in human palatal fibroblast 
adhesion, proliferation, and migration were studied in human palatal culture 
model by addition of inhibitor of sulfation or extraneous CS.  
 Stage 2: The expressions of CSPGs, chondroitin sulfate synthases (CHSYs) 
and chondroitin sulfate sulfotransferases (CHSTs) on human palatal 
fibroblast were evaluated in an in vitro wound model. 
 Stage 3: The importance of CS was evaluated through blocking down the 
expression of CHSY1 by RNA interference (RNAi) in human palatal 
fibroblast culture model.  
 Stage 4: The efficiency of extraneous CS on collagen-fibroblast-gel 
contraction was studied. 
 Stage 5: The expression of CS was investigated in the rabbit palatal wound 
model by monoclonal anti-CS clone CS-56.  
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3.1 Study on the roles of CS and its sulfate group in 2-D cell culture model. 
In this stage, cell culture study was conducted using ATCC CRL 1486 human 
embryonic palatal mesenchyme (HEPM) cells, a human fibroblast cell line, which 
was obtained from the American Type Culture Collection (Rockville, MD).  
Human palatal fibroblast cells were cultured under different conditions, such as 
with addition of chlorate or different sulfation type of CS. The changes of cell 
adhesion, cell proliferation and migration under each culture condition were 
evaluated.  
3.1.1 Culture of human palatal fibroblast  
Human palatal fibroblasts were cultured in 75cm2 tissue culture flasks (TPP, 
Trasadingen, Switzerland) in 90% minimum essential medium (MEM, Sigma, USA) 
with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium 
bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, and 
supplemented with 10% fetal bovine serum (FBS, Hyclone, Utah, USA), 50 U/ml 
penicillin G sodium, 50 µg/ml streptomycin sulfate (penicillin-streptomycin; Sigma, 
USA). The fibroblasts were subcultured. Cells between passages 12 and 16 were used 
for the present study. 
 
3.1.2 Subculturing procedure 
When the cells became confluence, the cell layer was rinsed with PBS solution to 
remove all traces of serum that contains trypsin inhibitor. 3ml 0.25% (w/v) 
Trypsin-0.53 mM EDTA solution was added to 75cm2 flasks. Cells morphology was 
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observed under an inverted microscope until cell layer was dispersed (usually within 5 
to 15 minutes). Then, 6.0 to 8.0 ml of complete growth medium was added.  Cells 
were aspirated by gently pipetting. Appropriate aliquots of the cell suspension was 
added into new culture vessels and incubateed at 37°C. 
3.1.3 Biological effect of the sulfate group of CS on palatal fibroblast activities 
3.1.3.1 Cell viability under various concentration of chlorate 
Human palatal fibroblasts were cultured in complete cell culture medium with 
addition of different concentrations (10mM, 20mM, 30mM, 60mM, 120mM and 
240mM) of sodium chlorate (Sigma, USA).  Cell viability and morphology were 
observed under phase contrast microscopy (OLYMPUS 1X70) till 24 hours after cell 
seeding. 
3.1.3.2 MTS assay  
According to previous study (Ouyang, et al. 2002), cells adhesion and 
proliferation can be evaluated by MTS assay, a colorimetric method for determining 
the number of viable cells in culture. CellTiter 96 Aqueous One Solution Cell 
Proliferation Assay (Promega, USA) contains MTS, a novel tetrazolium and PMS, an 
electrom coupling reagent. This MTS compound is bioreduced by cells into a colored 
formazan product that is soluble in cell culture medium.  
Assays were performed as following procedure:  
After thawing of MTS compound solution in a water bath at 37°C, master mix 
of 1:5 diluted MTS compound solution was prepared as follows (Table 3.1): 
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Component Volume/well 
MTS compound solution  30μl 
Complete culture medium  150μl 
Table 3.1  Master mix of 1:5 diluted MTS compound solution 
 
180μl diluted MTS solution was pipetted into each well of 24-well plate which 
is ready for testing. Plate was incubated for 1 hour at 37°C in a humidified, 5% CO2 
incubator. Cell viability in each well was then evaluated by recording the absorbance 
at 490nm using a spectrophotometric microplate reader. 
 
3.1.3.3 The effect of chlorate on palatal fibroblast adhesion 
 
3.1.3.3.1 Optimizing the time point for evaluating cell adhesion 
Human palatal fibroblasts were cultured in complete culture medium and 
cultured to 90% confluence. The adherent cells were trypsinized with 
0.25%Trypsin-EDTA solution and then counted using a hemocytometer.  
Cells were seeded into 24-well plate (BD Falcon, USA) at a density of 60,000 
cells/well in two groups (parallel samples of n=3): 
Group1: Complete culture medium (Control group) 
Group2: Complete culture medium with 30mM sodium chlorate (Sigma, 
USA)  
Plates were put into a humidified incubator (at 37℃, 5%CO2) for 4, 6, 8, and10 
hours respectively. The number of attached cells was quantified by MTS assay.  
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In both groups, the rate of cell adhesion was apparently slowed down after 8hr. 
So, the 8hr was chosen as the time point for following cell adhesion experiments.  
 
3.1.3.3.2 The effect of chlorate on palatal fibroblast adhesion 
Following the above procedure, human palatal fibroblasts were seeded into 
24-well plate at a density of 60,000 cells/well in five groups (parallel samples of 
n=3): 
Group1: Complete culture medium (Control group) 
Group2: Complete culture medium with 30mM sodium chlorate (Sigma, 
USA) 
Group3: Complete culture medium with 30mM sodium chlorate and 10mM 
sodium sulfate (Merck, Germany) 
Group4: Complete culture medium with 30mM sodium chlorate and 
100ng/ml C-4-S(Sigma, USA) 
Group5: Complete culture medium with 30mM sodium chlorate and 
100ng/ml C-6-S (Sigma, USA) 
Plates were placed into a humidified incubator (at 37℃, 5%CO2) for 8 hours. 
The number of attached cells was quantified by MTS assay. 
 
3.1.3.4 The effect of chlorate on palatal fibroblast proliferation 
Cells were seeded into 24-well plate at a density of 30,000 cells/well in five 
groups (parallel samples of n=6) 
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Group1: Complete culture medium (Control group) 
Group2: Complete culture medium with 30mM sodium chlorate (Sigma, 
USA) 
Group3: Complete culture medium with 30mM sodium chlorate and 10mM 
sodium sulfate (Merck, Germany) 
Group4: Complete culture medium with 30mM sodium chlorate and 
100ng/ml C-4-S(Sigma, USA) 
Group5: Complete culture medium with 30mM sodium chlorate and 
100ng/ml C-6-S (Sigma, USA) 
Plates were placed into a humidified incubator (at 37℃, 5%CO2) for 3 days 
(n=3) and 7 days (n=3). Proliferated cells were quantified by MTS assay. 
 
3.1.3.5 The effect of chlorate on palatal fibroblast migration 
Human palatal fibroblasts were seeded into 6-well plate and cultured to 90% 
confluence. Cells were “wounded” by scraping 3 horizontal lines across the bottom of 
6-well plate with a 1ml plastic pipette tip and then washed off the detached cells with 
PBS. 
Cells were cultured in five groups (parallel samples of n=3): 
Group1: Complete culture medium (Control group) 
Group2: Complete culture medium with 30mM sodium chlorate (Sigma, 
USA) 
Group3: Complete culture medium with 30mM sodium chlorate and 10mM 
sodium sulfate (Merck, Germany) 
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Group4: Complete culture medium with 30mM sodium chlorate and 
100ng/ml C-4-S (Sigma, USA) 
Group5: Complete culture medium with 30mM sodium chlorate and 
100ng/ml C-6-S (Sigma, USA) 
Plates were placed into a humidified incubator (at 37℃, 5%CO2) for 24 hours. 
Wound closure in each group was monitored under photographed under phase contrast 
microscopy at 12, 18 and 24 hours after scarping.  
. 
3.1.4 The effect of extraneous CS on cell adhesion and proliferation 
 
Cells were seeded into 24-well plate at a density of 30,000 cells/well in five 
groups (parallel samples of n=6) 
Group1: Complete culture medium (Control group) 
Group2: Complete culture medium with 100ng/ml C-4-S (Sigma, USA) 
Group3: Complete culture medium with 1000ng/ml C-4-S  
Group4: Complete culture medium with 100ng/ml C-6-S(Sigma, USA) 
Group5: Complete culture medium with 1000ng/ml C-6-S (Sigma, USA) 
Plates were placed into a humidified incubator (at 37℃, 5%CO2) for 8hours to 
evaluate cell adhesion and for 7 days to evaluate cell proliferation. The number of 
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3.2 Study on the expression of proteoglycan-CS on in vitro wound healing 
model (Stage 2) 
In stage1, it was investigated that the role of CS in and its sulfate group in human 
palatal fibroblast adhesion, proliferation, and migration.  In stage 2, the expressions 
of chondroitin sulphate proteoglycans (CSPGs), carbohydrate (chondroitin) synthases 
(CHSYs) and carbohydrate (chondroitin 4 and 6) sulfotransferases (CHSTs) were 
investigated in an in vitro 2-D wound model of human palatal fibroblast.  
3.2.1 An in vitro wounding model 
Human palatal fibroblasts were cultured to 90% confluence in 35mm culture dish 
and wounded by scraping with a 1ml pipette tip. Ten lines of defect were created 
horizontally and vertically respectively over the monolayer cells (Figure 3.1). Then 
the detached cells were washed off with 1xPBS. Cells were harvested for following 
experiments at 0 hr, 1 hr, 2 hr, 4 hr, 6 hr and 24 hr after being wounded. 
 
 
Figure 3.1 An in vitro wounding model 
3.2.2 Quantitative real time polymerase chain reaction (PCR) 
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3.2.2.1   Extraction of RNA 
Total RNA was extracted from cell pellets with a commercially available 
RNeasy mini kit (QIAGEN, Germany) according to the manufacturer’s instructions as 
follows. Human palatal fibroblasts were harvested from culture dishes and transfered 
to RNase-free 1.7ml microcentrifuge tubes (Axygen, USA), and pellet by 
centrifugation at 300 x g for 5 minutes. The supernatant were aspirated and the cell 
pellets were washed with PBS twice by centrifugation. The cell pellets were loosened 
thoroughly by flicking the tube and were lysed with 350ul buffer RLT (with addition 
of 3.5ul beta-ME) respectively. The lysates were passed at least 5 times through a 
20-gauge needle fitted to an RNase-free syringe. Then, 350µl 70% ethanol was added 
into the homogenized lysate for pipetting. The total of 700µl of the sample was 
applied to an RNeasy mini column placed in a 2ml collection tube and centrifuged for 
15s at 8000 x g. The flow-through was discarded. 700µl Buffer RW1 was added to 
wash the column by centrifugation. The RNeasy column was transferred into a new 
2ml collection tube, and washed twice with 500ul Buffer RPE by centrifugation for 
15s at 8000 x g. The flow-through was discarded and the RNeasy silica-gel 
membrande was dried by centrifugation for 2 min at 8000g. 30µl RNase-free water 
was added directly onto the RNeasy silica-gel membrane and the purifed total RNAs 
were eluted by centrifugation.  
Purified RNAs were measured by a Biophotometer (Eppendorf, Humburg, 
Germany). All RNA samples had an OD260: OD280 ratio in the range of 1.8 to 2.0. 
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3.2.2.2  Synthesis of cDNA 
Complementary DNA (cDNA) was synthesized from 3µg DNA-free total RNA 
with M-WLV reverse transcriptase (Promega, USA) and random primer (Invitrogen, 
USA).  
12.375µl of 3µg RNAs and appropriate volume of RNase-free water were added 
into 0.6ml microcentrifuge tubes (Axygen, USA). Then the mixture was heated to 
65ºC for 15 minutes to melt the secondary structure within the template. The tube was 
cooled down immediately on ice to prevent secondary structure from reforming. 
The following components were added to the annealed template in the following 
order: 
M-WLV 5 x reaction buffer           5µl 
Deoxynucleotide mixture             5µl 
Random primer                     1µl 
rRNasin Ribonuclease Inhibitor        0.625µl 
M-WLV Reverse transcriptase         1µl 
The above components were mixed gently by flicking the tube and incubated for 
60 minutes at 37 ºC. The mixture was heated at 95 ºC for 5 minutes immediately and 
the resultant cDNA was then diluted 10× in miliQ water. cDNA was stored at -20°C 
until use for real-time PCR.  
 
3.2.2.3  Real time PCR 
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3.2.2.3.1   Materials: 
A 1:10 final dilution of cDNA was used as the template for PCR analysis. Real 
time PCR was performed with Light Cycler System (Roche, USA), using QuantiTectTM  
SYBR Green PCR kit (QIAGEN, USA). The primers (synthesized by 1st Base, 


















Fwd: gaatcaactgctgcagacca  
(6532-6591) 
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(1709-1728) 
CHSY2 
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Table 3.2 Primers for quantitative real time PCR 
All primers were designed with Primer 3 (Rozen S, Skaletsky H 2000), a Web-based 
primer picking service at http://fokker.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi. 
The BLASTn version 2.2.2 (http://www.ncbi.nlm.nih.gov/blast) was used to compare 
the designed primers and the non-redundant nucleotide database. 
 
3.2.2.3.2 Real time PCR steps: 
2 x QuantiTect SYBR Green Master Mix, template DNA, primers, and RNase-free 
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Component Volume/reaction Final Concentration 
2 x QuantiTect SYBR Green Master Mix 5μl 1x 
Primer Forward 0.5μl 0.5μM 
Primer Reverse 0.5μl 0.5μM 
RNase-free water 3μl - 
Template DNA (added at step 4) 1μl - 
Total volume 10μl - 
Table 3.3 Master mix for Real-time PCR reaction 
The master mix was mixed thoroughly and dispensed appropriate volumes into 
PCR capillaries. cDNAs from different samples were added into the individual PCR 
capillaries. The LightCycler was programmed according to the program outlined in 
Table 3.4 and set fluorescence gains at channel 1 (F1, value 15)) 
Step Time Temperature Ramp 
PCR Initial activation step 15 min 95 °C 20 °C/s 
Denaturation 15 s 94 °C 20 °C/s 
Annealing 25 s 60 °C 20 °C/s 
3-step cycling  
(45 cycles) 
Extension 12 s 72 °C 20 °C/s 
Denaturation 0s 95 °C  
Incubation 15s 65 °C 0.1 °C/s 
Melting curve analysis 
 
 Heat to 0s 95 °C  
Cooling 30s 40 °C  
Table 3.4 Real-time cycler conditions for the LightCycler system 
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The PCR capillaries were placed into the LightCycler machine and the cycling 
program was started. At the end of the program, a melting curve analysis of PCR 
product was always performed to check if there was any abnormal amplification plot.    
And also, the specificity of PCR products was checked by 2% agarose gel 
electrophoresis. 
Agarose gel electrophoresis: The amplified products were removed from the 
LightCycler reaction capillaries by a short spin with capillaries inverted into 0.6ml 
PCR tubes and analyzed by agarose gel electrophoresis.10μl of the PCR reaction was 
electrophoresed on 2% agarose gel in the presence of ethidium bromide in TBE. The 
product size was determined by comparison to a 100bp ladder run on the gel.   
 
3.2.2.3.3 Analysis of PCR data 
 
The 2-ΔΔCT method was adopted to analyze the data (Livak, KJ, 2001). The 
fractional cycle at which reporter fluorescence generated by dsDNA-binding dye 
(SYBR) passes above baseline is defined as the threshold cycle (CT). ΔCT is equal to 
the difference in threshold cycles for target and reference (CT, target-CT, GAPDH). 
Subsequently, the ΔΔCT values were calculated by subtracting the ΔCT value of the 
control samples at each time point from ΔCT value of the wounded samples at same 
time points: ΔΔCT = (CT, target-CT, GAPDH)Time x-(CT, target-CT, GAPDH) Time 0. Changes in gene 
expression were reported as fold increases (2-ΔΔCT) relative to untreated controls. 
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Using this analysis, the value of the mean fold change at time zero should be very 
close to one (20 = 1). In this study, β-actin is served as a reference gene, and the 
CSPGs, CHSYs, CHSTs as target genes.  
The ∆∆CT method was justified for use only when the amplification efficiency 
of the target was approximately equal to that of the reference. The efficiency was 
assessed by calculating the ∆CT variation correlating with the template dilution. The 
cDNA template was diluted gradually over an 100-fold range. For each diluted sample, 
amplification was performed for beta-actin and the targets. ∆CT was determined by 
the formula: CT, target-CT, GAPDH. A plot was made based on log cDNA dilution versus 
∆CT. The efficiencies of the target and the reference are regarded as approximately 
equal when the absolute value of the slope is close to zero. 
 
3.3. Study on the function of CS through knocking down CHSY1 by RNAi  
In order to illustrate the biological function of chondroitin, three siRNAs (Table 
3.5) were custom-designed and synthesized by Ambion (USA). siRNAs were 
transfected into cultured cells to block down the expression of  chondroitin synthase 
1 (CHSY1) and then the subsequent changes of cell activities were evaluated. In the 
experiment, SilencerTM siRNA transfection II kit (Ambion, USA) was used to transfer 
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SiRNA ID Target gene  RefSeq Number Sequence (5’-3’) 
22134 CHSY1 NM_014918 Sense:     ggaacuuucucuucgugggtt 
Antisense:  cccacgaagagaaaguucctg 
22230 CHSY1 NM_014918 Sense:     ggguucugacacaucuguatt 
Antisense:  uacagaugugucagaaccctc 
22326 CHSY1 NM_014918 Sense:     ggauuuggcauuuucucuutt 
Antisense:  aagagaaaaugccaaaucctt 
Table 3.5 Three custom-designed and synthesized siRNAs  
 
3.3.1 Experimental design:  
In each experiment, three controls were used as follows: 
Positive control siRNA 
Glyceraladehyde-3-phosphate dehydrogenase (GAPDH) siRNA When 
successfully transfected, the GAPDH siRNA reduces both the mRNA and 
protein levels of GAPDH in human cell lines. This slows the growth rate of 
the cells and reduces the rate of cell proliferation of most cell types. 
Negative control siRNA  
Negatvie Control siRNA is a scrambled sequence that has no significant 
homology to the human genome and have no effect on the mRNA and protein 
levels of GAPDH, it serves as a baseline for measuring the effects of the 
GAPDH siRNA.  
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Buffer-only control   
In order to control for any nonspecific transfection, a sample-well that is 
mock-transfected with OPTI-MEM medium and siRNA buffer, but lacks 
transfection agent and siRNA, was always included. 
 
3.3.2 Optimizing siRNA Transfection Conditions 
The most important parameter for optimization of siRNA delivery is the 
amount of transfection agent used. There were two tranfection reagents for 
optimizing high levels of knockdown and cell viability.    
The adherent cells were trypsinized as normal procedure, and 
resuspended to 1 x 105 cells/ml in Opti-MEM I medium (Gibco Invitrogen 
Corp. USA). Transfection reagent was prepared according to the following 
table (Table 3.6) and incubated at room temperature for 10 minutes. 0.75μl of 
20μM siRNAs (for a final comcentration of 30nM) were diluted in 
opti-MEM I to a final volume of 25μl. Each 25μl diluted siRNAs were added 
into 25μl diluted transfection reagent and mixed well for 10 minutes of 
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siPORT NeoFX Transfection agent 
siPORT NeoFX (μl) 1  1.5 2 2.5
Opti-MEM I(μl) 25 25 25 25
 
siPORT Amine Transfection agent 
siPORT Amine (μl) 2  2.5 3 3.5
Opti-MEM I(μl) 25 25 25 25
Table 3.6 Dilution of the transfection agent in Opti-MEM I medium 
 
After incubation, RNA/transfection reagent complexes were dispersed into 
24-well plate. 450μl of prepared cell suspension were then added into wells 
containing 50μl RNA/transfection reagent complexes. The plate was gently shaken 
back and forth to evenly distribute the complexes and incubated at 37°C. Transfection 
medium was replaced by fresh complete medium (without antibiotics) after 24 hours 
transfection.  
After 48 hours of transfection, real-time PCR was carried out to evaluate 
knockdown efficiency of CHSY1 and MTS assay was used to evaluate cell viability.  
 
3.3.3 MTS assay for evaluating cell viability  
After thawing of MTS compound solution in a water bath at 37°C, master mix 
of 1:5 diluted MTS compound solution was prepared. 
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180μl diluted MTS solution was pipetted into each well of a 24-well plate 
which was ready for testing. Plate was incubated for 1 hour at 37°C in a humidified, 
5% CO2 incubator. Cell viability in each well was then evaluated by recording the 
absorbance at 490nm using a spectrophotometric microplate reader. 
 
 
3.3.4 Real-time PCR for evaluating knockdown efficiency 
 
Cells-to-cDNA II (Ambion, USA) was used to synthesis cDNA directly from 
mammalian cells in culture without isolating RNA.  
Real time PCR was performed with Light Cycler System (Roche, USA), using 
QuantiTectTM  SYBR Green PCR kit (QIAGEN, USA). The primers CHSY1 (1st 
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Table 3.7  Forward and reverse primers (5′→3′) used for Real-time PCR 
3.3.5 The effect of knockdown CHSY1 on cell adhesion and proliferation. 
Human palatal fibroblasts were transfected with siRNA (ID: 22326) targeted to 
CHSY1 in 24-well plate. After 48 hours of transfection, cells were trypsinized and 
counted using hemocytometer (Sigma, USA).  
Cells were seeded into 24-well plate (BD Falcon, USA) at a density of 60,000 
cells/well in two groups (parallel samples of n=3): 
Group1: Cells without transfection (Control group) 
Group2 : Cells with transfection 
Plates were placed in a humidified incubator (at 37℃, 5%CO2) for 8 hours to 
evaluate cell adhesion or for 3 days to evaluate cell proliferation respectively. The 
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number of attached cells was quantified by MTS assay.  
 
3.3.6 The effect of knockdown CSHY1 on cell migration. 
Human palatal fibroblasts were transfected with siRNA (ID: 22326) targeted to 
CHSY1 in 6-well plates (BD Falcon, USA). After 48 hours of transfection, cells with 
or without siRNA transfection were “wounded” by scraping 3 lines horizontally 
across the bottom of plate with a 100μl plastic pipette tip (Axygen, USA). Then, 
wound closure was monitored and photographed under a phase contrast microscope 
(Olympus 1X70) at 12, 18 and 24 hours after scraping.  
The distance between the wound edges was measured by MicroImage (version 
4.5.1.22). The rate of cell migration was evaluated by the percentage of migrated 
distance compared to initial distance. 
 
3.3.7 The effect of knockdown CHSY1 on cell cycle. 
Human palatal fibroblasts were transfected with siRNA (ID: 22326) targeted to 
CHSY1 in 6-well plate. After 48 hours of transfection, cells were harvested and 
resuspended in 0.5 ml PBS to achieve a single-cell suspension, and transferred to the 
tubes containing 4.5 ml of 70% ethanol. Cells were fixed at 4oC for subsequent flow 
cytometry testing.   
PI staining for flow cytometry 
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The above ethanol-suspended cells were centrifuged for 5 minutes at 200xg and 
ethanol was then decanted thoroughly. Cell pellet was resuspended in 1 ml PBS 
containing 1 mg/ml ribonuclease (Sigma, USA) and 50 μg/ml PI (Sigma, USA) and 
incubated for 15 minutes at 37 oC. The flow cytometer was set up and adjusted for 
excitation with blue light and detection of PI emission at red wavelengths. At least 
10000 events were collected for each sample. Cell fluorescence was measured in the 
flow cytometer. The pulse width-pulse area signal was used to discriminate between 
G2 cells and cell doublets and the latter was gated out. DNA content was analyzed 
using Windows Multiple Document Interafce for Flow Cytometry (WinMDI, version 
2.8; from website:http://facs.scripps.edu/software.html) 
 
 
3.4 Study on the function of CS on 3-D palatal fibroblast culture model.  
3.4.1 Preparation of neutralized, isotonic Vitrogen Collagen solutions 
Eight parts of chilled 3.0 mg/ml bovine dermal collagen type I (Vitrogen 100, 
Cohesion Corp., Palo Alto, CA) were mixed with one part of 10x MEM (Sigma, USA) 
and one part of 0.1 M NaOH (Sigma, USA). The pH of the solution was adjusted to 
7.4 by the addition of a few drops of 0.1M HCl (Sigma, USA) or 0.1 M NaOH. The 
pH of the solution was monitored by a pH paper. The neutralized, isotonic Vitrogen 
Collagen solution then was stored at 4°-6°C for several hours prior to gelation. 
Monolayer cultured cells were trpsinized and counted as usual procedure. 100 x 10 4 
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cells/ml was suspended in prepared Vitrogen Collagen solution. 300µl of cell-gel 
suspention was casted into each well of 24-well plate. 
3.4.2 Gelation of neutralized, isotonic Vitrogen Collagen solutions.  
24-well plate was transferred to incubator and collagen gelation (fibrillogenesis) 
was initiated by warming the neutralized Vitrogen Collagen solution to 37°C and 
finished within 60 minutes. 500µl complete culture medium w/o additives (30mM 
chlorate, 100ng/ml C-4-S, 100ng/ml C-6-S) were added into each well respectively. 
The gel contraction was observed and photographed by Nikon Digital Sight DS-L1 
camera within 72 hours. Gel area was measured with ImageJ, an image analyzer 
(http://rsb.info.nih.gov/ij/). Data were expressed as the percentage of contracted gel 
area compared with the initial gel area. 
 
3.5 Study on the expression of CS during palatal wound healing 
 
An in vivo wound-healing model made on the palatal mucosa of 11-week male 
New Zealand White (NZW) rabbits was used. The healing procedure was evaluated 
and the expression of CS was observed by immunohistochemistry technique. 
 
3.5.1 Animal model 
A total of 16 adult male 11- week old New Zealand White rabbits were used. 
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Rabbits were randomly assigned to 8 sub-groups (a-h, n=2 for each sub-group) on the 
day of surgery.  
Rabbits were weighed respectively and their weights are from 3 to 3.5kg. The 
required dosage of anaesthetic drug for each rabbit was calculated. At first, Hypnorm 
(fentanyl citrate 0.315 mg/ml and fluanisone 10 mg/ml; Jansen Animal Health, UK) 
was given subcutaneously at the dosage of 0.3 ml/kg body weight. Rabbits became 
drowsy after 3 minutes. Then 0.2 ml Dormicum (Midazolam 5 mg/ml, Roche, 
Germanny) was injected via the ear central vein for induction of anesthesia, and then 
0.1 ml was administrated each time subsequently for maintenance. The total dosage 
used is at the dosage of 2 mg/kg body weight. Pain reflex was tested after each drug 
injection. 
The mouth of anaesthetized rabbit was opened by a custom-made frame for good 
exposure of operation field. The selected wound area is adjacent to the middle three 
molar teeth on the tight half of the hard palate. A sterile cotton gauze was placed 
before the throat to prevent aspiration of blood. Xylocaine (2% ligocaine 
hypochloride with 1:80000 adrenaline, Astra, USA) were injected at the wound area 
to minimize bleeding. A 2mm by 4mm wound was made with a No. 12 blade. The 
periosteum was separated from the underlying bone and detached together with the 
palatal mucosa leaving only the denuded palatal bone. The wound was covered with a 
gauze pad to prevent bleeding.  
After operation, rabbits were administrated with both Temagesic (Buprenorphine 
0.3 mg/ml, Schering, UK) for analgesic purposes and the antibiotic Rilexine 150 
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(100ml contains 15 ml Cephalexin monohydrate, Fermark, Mexico) at a dosage of 0.1 
mg/kg body weight once a day for three days. 
The rabbits were allocated randomly to be sacrificed at 1, 3, 5, 7, 14, 21, 30, and 
60 days post-surgery. The maxilla was removed from the rabbit mouth and the tissue 
from the wound site, including a border of tissue external to and around the wound 
edge was dissected and fixed in 10% neutral paraformaldehyde solution. A similar 
sized tissue was also harvested from the contralateral unwounded side and served as a 
control.  
 
3.5.2 Tissue preparation for paraffin section 
Harvested experimental and control tissues were fixed in 10% neutral 
paraformaldehyde solution for at least 24 hours. Tissue samples were dehydrated in 
ascending percentage (50%, 70%, 80%, 90% and 100%) of alcohol for 30 minutes 
each, in equal parts of absolute alcohol and Toluene for 60 minutes, and then cleared 
in Toluene for 60 minutes twice. Cleared tissue samples were infiltrated in 4 pots of 
wax in a 60 ºC oven and embedded in wax blocks at the end. A series of 4 µm 
thickness sections were cut using a microtome and mounted onto the albuminised 
glass slides.  
 
3.5.3 Haematoxylin & Eosin Staining (H & E staining) 
One section of tissue sample was selected from every 50 serial sections to be 
stained by H & E till the wound site was found with incontinuous epithelium or newly 
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formed epithelium with disorganized collagen fibres in the dermal layers. 
Slides were deparaffinized in two changes of Xylene, equal parts of Xylene and 
absolute alcohol, and rehydrated in a descending percentage (100%, 90%, 80%, 70%, 
50%) of alcohol and two changes of deionised water. The slides were left in each 
solution for approximately 1 minute.  
Slides were immersed into filtered Haematoxylin solution for 15 minutes and 
washed with deionised water. Stained slides were differentiated in a Differentiating 
Fluid (70% alcohol with a few drops of hydrochloric acid) for 30 seconds. Checks 
under the microscope were made to see if differentiating was all right. If under 
differentiated, the slide were immersed in the differentiating fluid again. If over 
differentiated, wash the slides were wounded thoroughly in water then re-stained.  
Sections were blued in tap water for 10 minutes and then followed by rinsing in 
deionised water. After that, sections were immersed into a 1-3% Eosin solution for 5 
minutes. 
Finally, dehydration of sections were performed quickly in 90% alcohol, two 
changes of absolute alcohol, equal parts of absolute alcohol and Xylene, and three 
changes of Xylene. The sections were mounted with cover slips and ready for 




The primary antibody used was mouse monoclonal anti-chondroitin sulfate 
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clone CS-56 (Mouse IgM isotype) (Sigma, USA). It was derived from the hybridoma 
produced by the fusion of mouse myeloma cells and splenocytes from an immunized 
mouse. The secondary antibody was biotinylated goat anti-mouse IgM in 
VECTASTAIN ABC kit (Vector labs, UK). 
The sections were deparaffinised in two changes of Xylene, hydrated in a 
descending percentage (100%, 90%, 80%, 70%, 50%) of alcohol and rinsed with two 
changes of deionised water. Each section was incubated in 3% hydrogen peroxide in 
phosphate-buffered saline (PBS) for 15 minutes at room temperature to inactivate the 
endogenous peroxidase activity. After washing with PBS, sections were drawn 
boundaries using ImmEdge™ Pens (Vector, UK). 1% bovine serum albumin (BSA, 
Sigma, USA) in PBS was applied on each section for 30 minute at room temperature 
to block non-specific antigen. Then each section was incubated with 100µl CS56 at a 
concentration of 1:300 diluted with 1% BSA in PBS for one hour at room temperature 
in a humidified chamber. After incubation, sections were washed with three changes 
of PBS, and then incubated with 100µl of 1:200 anti-mouse IgM for 30 minutes at 
room temperature. After washing with PBS, sections were incubated with 100µl 
StreptAvidin-biotinylated HRP from ABC kit for 10 minutes at room temperature. 
Diaminobenzidine (DAB, Vector Laboratories, UK) solution was applied onto each 
section for 10 minutes at room temperature. Subsequently, sections were 
counterstained with filtered Mayer’s Haematoxyln for 2 minutes, rinsed in running tap 
water, dehydrate through ascending grades of alcohol, cleared in Xylene, and mounted 
with mounting media DePX. 
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Chapter IV Results 
4.1 Study on the roles of CS and its sulfate group (Stage 1) 
 
4.1.1 Biological effect of the sulfate group of CS on palatal fibroblast activities 
Chlorate is an inhibitor of glycosaminoglycan sulfation, and has been used in cell, 
organ, and whole embryo cultures to inhibit sulfation with no significant effect on 
glycosaminoglycan or protein synthesis or on cell viability (Conrad, 1998; Yip et al., 
2002). It acts by competing with sulfate in the synthesis of 
3-phosphoadenosine-5-phosphosulfate, the sulfate donor for glycosaminoglycan 
sulfation.  
 
4.1.1.1 Cell viability under various concentration of chlorate  
     A series of concentrations of chlorate were added to human palatal fibroblasts in 
culture with the aim of optimizing concentration for following studies.  
Six groups (n=3) of human palatal fibroblasts were treated with 10mM, 20mM, 
30mM, 60mM, 120mM and 240mM chlorate respectively. Cell morphology and 
viability were observed under a phase contrast microscope at 8hr, 12hr and 24hr after 
cell seeding.  
There were no obvious differences on cultured cell morphology at 10mM, 20mM, 
30mM, 60mM, and 120mM chlorate. Cells appeared healthy and had the same 
spindle-shaped morphology as those in the control group cultured in chlorate-free 
medium. However, very significant changes were observed when cultured fibroblasts 
were treated with 240mM chlorate, where all the cells died and lost their normal 
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shape (Figure 4.1.1). 
 
  
< 120mM 240mM 
Figure 4.1.1 Morphology change of palatal fibroblast when treated with different 
concentration of chlorate 24 hour after cell seeding. 
 
It has been shown that 30mM chlorate was sufficient to abolish chondroitin 
sulfation completely (Yip et al., 2002). To determine if the sulfate group of CS is 
necessary for the biological activity of the molecule, the effects on cell adhesion and 
cell proliferation of palatal fibroblasts treated with 30mM chlorate have been studied 
as follows.  
 
4.1.1.2 The effect of chlorate on palatal fibroblast adhesion 
Two groups of palatal fibroblasts was exposed to normal culture medium or 
30mM chlorate and then MTS assay was done at 4, 6, 8,10hr after cell seeding. 
Compared to the control group, the chlorate-treated group of palatal fibroblasts 
exhibited fewer adherent cells at 4, 6, 8 and 10 hours (student t-test, n=3, p<0.05). In 
both groups, the rate of cell adhesion apparently slowed down after 8hr. (Figure 4.1.2 
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A). As such, 8hr was chosen as the time point for following cell adhesion 
experiments.  
To confirm that the effect of chlorate on cell adhesion was due to competitive 
inhibition of GAG sulfation rather than to the toxicity of chlorate, palatal fibroblasts 
were cultured in the presence of normal medium, chlorate or chlorate plus sulphate. 
Exogenous sulphate in the culture medium has predicted to compete out the effect of 
chlorate in inhibiting GAG sulphation. As 10mM exogenous sulphate was able to 
block the effect of 30mM chlorate in inducing premature neuropore closure (Yip, et 
al., 2002), 10mM sulphate was adopted in this study. 
As shown in Figure 4.1.2 B, chlorate exhibited an inhibitory effect on cell 
adhesion with fewer adherent cells. When cells were cultured in the medium with 
chlorate and 10mM sulphate together, cell attachment can be partially recovered by 
















































A. The effect of chlorate on palatal fibroblast 
adhesion 
B. The effect of chlorate on palatal fibroblast 
adhesion at 8hr. 
Figure 4.1.2 The effect of chlorate on palatal fibroblast adhesion 
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4.1.1.3 The effect of chlorate on palatal fibroblast proliferation 
Human palatal fibroblasts proliferation was assessed after 3 or 7 days of culture 
in the normal medium, chlorate or chlorate plus sulphate. Day 3 and day 7 were 
chosen as the observation time points. As shown in Figure 4.1.3, fibroblast 
proliferation was consistently slower in the chlorate-treated group at days 3 and 7, and 
sulphate can partially recover the inhibitory effect of chlorate on cell proliferation 


























Figure 4.1.3 The effect of chlorate on palatal fibroblast proliferation 
 
4.1.1.4 The effect of chlorate on palatal fibroblast migration 
An in vitro wound closure model where 'wounding' was achieved by horizontal 
scraping across the bottoms of wells containing 90% confluent palatal fibroblasts was 
used (Guo et al., 2003).With this in vitro wounding healing model, the effects of 
chlorate on palatal fibroblast migration were investigated.  
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The rate of wound closure was determined by measuring the distance between 
the wound edges at 12, 18 and 24 hours after wounding occurred. As shown Figure 
4.1.4, starting with an average wound gap of 489µm, the distance decreased by 92.7% 
after 18 hrs. In contrast, the rate of wound closure was dramatically slower in the 
chlorate-treated group, with only 39.9% reduction in wound gap distance 18 hrs after 
wounding occurred. Compared to chlorate group, the chlorate-sulphate group 
exhibited narrower wound gap at 18 hour (one-way ANOVA, n=3, P<0.05). This 
suggests that sulphate can partially reversed the inhibitory effect of chlorate on palatal 
fibroblast migration.  
The above result shows that glycosaminoglycans are possibly involved in cell 
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4.1.2 The effect of extraneous CS on cell activities 
Disaccharides in CS chains are often sulfated in Position 4 or 6, which are named 
chondroitin-4-sulfate (C-4-S) for sulfated position 4 and chondroitin-6-sulfate (C-6-S) 
for sulfated position 6 respectively. The biological effects related to structure were 
investigated in the following experiments. 
 
4.1.2.1 Chondroitin sulfate regulates palatal fibroblast adhesion 
To determine if CS is involved in regulating palatal fibroblast adhesion, 
fibroblasts were cultured in the presence of chondroitinase ABC, an enzyme that 
breaks down CS. As shown in Figure 4.1.5, degradation of endogenous CS resulted in 
a significant reduction in the number of adherent cells (Student t-test, n=3, p<0.05), 
























Figure 4.1.5The effect of chondroitinase ABC on palatal fibroblast adhesion 
 
Furthermore, culture medium supplemented with 100 ng/mL or 1000 ng/mL of 
74 
Chapter IV Results 
exogenous chondroitin-6-sulfate led to a dose-dependent increase in cell adhesion 























Figure 4.1.6 Titration of chondroitin-6-sulfate on palatal fibroblast adhesion 
 
On the contrary, palatal fibroblasts cultured for 8 hrs in a medium supplemented 
with chondroitin-4-sulfate showed a dose-dependent reduction in cell adhesion 
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Figure 4.1.7 Titration of chondroitin-4-sulfate on palatal fibroblast adhesion 
 
 
4.1.2.2 Chondroitin sulfate regulates palatal fibroblast proliferation 
Also, the effect of exogenous CS on cell proliferation was studied, as measured 
by the number of metabolically active cells after a seven-day culture period (Figure 
4.1.8). Firstly, degradation of endogenous CS resulted in a significant reduction in the 
number of proliferated cells (Student t-test, n=3, p<0.05), hereby, suggesting that CS 

























Figure 4.1.8 The effect of chondroitinase ABC on palatal fibroblast proliferation 
 
Figure 4.1.9 showed that palatal fibroblasts cultured in the presence of 
chondroitin-6-sulfate over a seven day period show a dose-dependent increase in cell 
numbers (one-way ANOVA, n=3, p <0.05). 
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Figure 4.1.9 Titration of chondroitin-6-sulfate on palatal fibroblast proliferation 
 
Same result showed that continuous supplementation of the culture medium with 
chondroitin-4-sulfate led to a dose-dependent increase in cell numbers after a 
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4.1.2.3 Chondroitin sulfate regulates palatal fibroblast migration 
 
With the in vitro wounding healing model, the effect of chondroitinase ABC on 
palatal fibroblast migration was investigated. As shown in Figure 4.1.11, the distance 
decreased by 75.3% 18 hrs after wounding occurred compared with 92.6% reduction 
in control group (Student t-test, n=3, p<0.05). Both groups showed a completely 
closed wound at 24 hours after wounding. 
In the presence of C-6-S or C-4-S, the rates of closure have no statistical 
difference from control group at the concentration of 100ng/ml and 1000ng/ml at the 










































































Control C-6-S 100ng C-6-S 1000ng
 
Figure 4.1.11 Chondroitin sulfate regulates palatal fibroblast migration 
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4.1.2.4 Requirement for sulfate group for biological activity of chondroitin sulfate 
and biological effect of sulfate group position in chondroitin sulfate. 
To determine the necessity of sulfate group of CS on cell activities and if the 
position of the sulfate group in CS influences its biological action, the following 
experiments were carried out.  
The results show that supplementation of chlorate-containing culture medium with 
exogenous chondroitin-6-sulfate resulted in an increase in cell adhesion, while 
supplementation with exogenous chondroitin-4-sulfate resulted in a further decrease in cell 
adhesion (Figure 4.1.12), as compared with cells exposed to chlorate alone (one-way 






















Figure 4.1.12 The effect of sulfate group of chondroitin sulfate on palatal fibroblast adhesion 
 
As shown in Figure 4.1.13, supplementation of chlorate-containing culture medium 
with both exogenous chondroitin-4-sulfate and chondroitin-6-sulfate resulted in an increase 
in cell proliferation (one-way ANOVA, n=3, p<0.05). 
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Figure 4.1.13 The effect of sulfate group of chondroitin sulfate on palatal fibroblast proliferation
 
With in vitro wounding healing model, the effect of sulfate group in GAG and 
the specific sulfate position on palatal fibroblast migration was investigated. As 
shown Figure 4.1.14, starting with an average wound gap of 489um, the distance 
decreased by 92.7% at 18 hrs after wounding occurred. In contrast, the rate of wound 
closure was dramatically slower in the chlorate-treated group, with only 39.9% 
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reduction in wound gap distance at 18 hrs. This shows that sulfate group of 
glycosaminoglycans are involved in cell migration and wound closure. The 
requirement for CS in this process is further supported by the finding that wound 
closure in the presence of chlorate with addition of exogenous chondroitin-4-sulfate 
or chondroitin-6-sulfate were significantly faster than in samples cultured in the 


















Control Chlorate Chlorate+C-4-S Chlorate+C-6-S
 
Figure 4.1.14 The effect of sulfate group of chondroitin sulfate on palatal 
fibroblast migration 
 
In summary, the present results of the stage 1 study shows that sulfation of CS 
and CS sulfation pattern have an effect on human palatal fibroblast activities. These 
findings were achieved by addition of chemical inhibitors or extraneous CS. In order 
to further illustrate the relationship between CS and wound healing, the expression 
and function of CS and its related genes were investigated in the following stages of 
experiments.   
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4.2 Study on the expression of CSPGs, CHSYs and CHSTs on in vitro wound 
healing model (Stage 2)  
 
Real-time PCR was used to examine the mRNA expression of various CS related 
genes, which are classified into three groups: CSPGs, CHSYs and CHSTs. Generally, 
the RNA expression of CSPGs is responsible for CS core proteins, CHSYs for 
biosynthesis of CS chains, and CHSTs for sulfation of CS chains. 
The aim of this stage 2 study is to investigate the time-course expression of CSPGs, 
CHSYs and CHSTs after wounding. Real-time PCR technology has been explored as a 
main method to quantify the expression of mRNA. At first, real-time PCR was 
performed on template cDNA with up to 100 folds of dilution to look at if the 
amplification efficiencies of the target and reference are equal. Here, reference gene 
used is β-actin with a 132kb PCR product. Then, fold changes of target gene 
expression normalized to reference gene was presented by relative quantification, 
2-∆∆CT method. 
cDNA synthesized from 3 µg total RNA was diluted to 1:1, 1:2, 1:5, 1:10, 1:20, 
1:50, and 1:100. For each dilution sample, DNA amplifications were performed using 
respective primers of target genes and reference gene. If the absolute value of the slope 
is close to zero, the efficiencies of the target and reference genes are similar, and then 
2-∆∆CT method can be used. The ∆CT (CT, CSPG1 –CT, β-actin) was calculated for serial 
dilution.  A plot of the log cDNA dilution versus ∆CT was made. Values were mean ± 
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SE from three separate experiments. The data were analyzed by using least-squares 
linear regression analysis. 
 
 
4.2.1 CSPGs mRNA levels 
 
4.2.1.1 The amplification efficiency of CSPGs versus reference gene 
Figure 4.2.1 show that the amplification efficiency of CSPGs synthesized by 
designed primers is close to that of β-actin. The slope of the line is 0.0273(CSPG1), 
0.0222(CSPG2), 0.0245(CSPG3), 0.0901(CSPG4), and 0.042(CSPG6). All these 
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 Figure 4.2.1 The amplification efficiency of CSPGs versus reference gene 
 
 
4.2.1.2     Melting curve analysis for reference genes and CSPGs 
 
4.2.1.2.1    Melting curve analysis for reference genes 
Melting curve analysis was carried out at the each end of PCR reactions to verify 
specificity and identity of the PCR products. Figure 4.2.2 shows a melting curve for 
the detection of β-actin with only one peak at 83.5.  





Figure 4.2.2  Melting curve analysis for the detection of β-actin in samples by 
real time PCR. 
 
 
4.2.1.2.2    Melting curve analysis for CSPGs 
Figure 4.2.3 shows a melting curve for the detection of CSPGs with only one 
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4.2.2    CHSYs mRNA levels 
 
4.2.2.1  The amplification efficiency of CHSYs versus reference gene 
Figure 4.2.4 shows that the amplification efficiency of CHSYs synthesized by 
designed primers is close to that of β-actin. The slope of the line is 0.046 for CHSY1, 
0.0464 for CHSY2, and 0.0889 for CHSY3. All these values are close to zero. 
Therefore, 2-∆∆CT method can be used.  
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Figure 4.2.4 Amplification efficiency of CHSYs relevant to reference gene 
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4.2.2.2   Melting curve analysis for CHSYs 
Figure 4.2.5 shows a melting curve for the detection of CHSYs with only one 
peak at 83 for CHSY1, 79.8 for CHSY2, and 79.8 for CHSY3. 
 
Figure 4.2.5 Melting curve analysis for the detection of CHSYs in samples by 
real time PCR. 
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4.2.3   CHSTs mRNA levels 
 
4.2.3.1  The amplification efficiency of CHSTs versus reference gene 
Figure 4.2.6 shows that the amplification efficiency of CHSTs synthesized by 
designed primers is close to that of β-actin. The slope of the line is 0.024(CHST2), 
0.0838 for CHST4, 0.053 for CHST6, 0.0231 for CHST7, 0.0243 for CHST8, and 
0.0586 for CHST10. All these values are close to zero. Therefore, 2-∆∆CT method can 
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Figure 4.2.6 Amplification efficiency of CHSTs relevant to reference gene 
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4.2.3.2   Melting curve analysis for CHSTs 
Figure 4.2.7 shows a melting curve for the detection of CHSTs with only one 
peak at 86.6for CHST2, 83.2for CHST4, 83.2for CHST6, 81.2for CHST7, 
86.2 for CHST8, and 82.2for CHST10. 
 




Figure 4.2.7 Melting curve analysis for the detection of CHSYs in samples by 
real time PCR. 
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4.2.4   The expression of CSPGs on in vitro wound healing model 
Total RNA was extracted on 0, 1, 2, 4, 6, 24 hours after wounding and real-time 
PCR was carried out. Expression of target genes was normalized to GAPDH 
expression and compared to the control groups without being wounded respectively. 
The results show that the expression of CSPG (1,2,3,4,6) increased and reached a peak 
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4.2.5    The expression of CHSYs on in vitro wound healing model 
Also the expression of CHSY(1,2,3) which are for biosynthesis of CS chains, 
increased and reached to a peak during 1-2 hour after wounding and then decreased to 
initial level after that (Figure 4.2.9 ). 
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4.2.6   The expression of CHSTs on in vitro wound healing model 
Similarly, CHST (2, 4, 6, 7, 8, and 10) increased and reached a peak during 1-2 
hour after wounding and then decreased to its initial level after that (Figure 4.2.10). 
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Figure 4.2.11 Fold change of CS related gene expressions on CRL-1486 at the first 2 hours 
after wounding. 
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Fold changes of 5-26 were presented during the initiated 1-2 hours after wounding 
(Figure 4.2.11).  It implies that CS related genes have a quick response to injury. 
The findings from the in vitro wound model of this stage 2 study show that the 
expression of CS related genes changed after wounding. Together with the findings of 
stage 1, they suggest that CS and CS related genes are involved in palatal wound 
healing and may regulate wound healing. In the following stage of experiments, the 
biological function of CS on cell activities was investigated by RNAi technique 
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4.3. Study on the function of CS through knocking down CHSY1 by RNAi 
(Stage 3) 
 
Recently Mizuguchi S and colleagues (2003) reported that chondroitin is 
essential in cytokinesis of C. elegans. So the aim of stage 3 experiment was to 
investigate whether chondroitin has a similar biological function in human cells. 
RNAi technique was used to specifically suppress the mRNA level of CHSY1 on 
human palatal fibroblast culture model, and the subsequent effects on cell activities 
were then observed. 
Three 21-nucleotide CHSY1 siRNAs (#134, #260 and #324) were 
custom-designed and synthesized. The siRNAs were then transferred into human 
palatal fibroblasts using silencer siRNA transfection kit. At the same time, negative 
GAPDH siRNA, which is not complementary to any gene in our target cell, was used 
as a negative control to identify changes in gene expression that result from the 
siRNA delivery method. Cultures were treated with siRNAs for 48 hours and then 
followed by real-time RT-PCR to evaluate the suppression effects on mRNA level of 
CHSY1.  
 
4.3.1. Optimizing transfection conditions 
Palatal fibroblasts were transfected during plating with a siRNA targeting GAPDH or 
Negative Control siRNA. Forty eight hours post-transfection, GAPDH expression was 
measured by real-time RT-PCR. Percent gene expression was calculated as GAPDH 
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gene expression in GAPDH siRNA transfected cells compared to those transfected 
with the Negative Control siRNA. Here, β-actin served as a reference gene.  
siRNAs targeting to GAPDH were transferred into human palatal fibroblast 
under different amounts of siPORT NeoFXTM (1μl, 1.5μl, 2μl, 2.5μl) in the same 
culture system. Figure 4.3.1 showed the remaining GAPDH expression by real time 
PCR and cell viability by MTS assay at 48 hours after transfection under those series 
amount of siPORT NeoFXTM. A 2μl of siPORT NeoFX gave the best knockdown 
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Figure 4.3.1. Transfection efficiency and Cytotoxicity of siPORT NeoFXTM on human 
palatal fibroblasts 
 
Since both high knockdown efficiency (83.5%) and high cell viability (95.4%) 
were achieved by 2μl siPORT NeoFX, the other transfection conditions, such as 
exposure time to transfection reagent, amount of siRNA and cell density, were not 
optimized subsequently.  
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4.3.2. Test siRNA of interest  
Three siRNAs (#134, #260 and #324) against CHSY1 were custom-designed by 
Ambion. The parameters extablished by the above optimization experiments were 
used to perform transfection with there three siRNAs.  
#326 showed the highest transfection efficiency with 82.6%, #134 is 76%, and 
#230 is 66.3%.  
All cells showed good viability under light microscopy and MTS results showed 
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Figure 4.3.2. Transfection efficiency of custom-designed siRNAs on human palatal 
fibroblasts 
 
4.3.3. Cell function assay related to the effects of RNAi on CHSY1 
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This step aimed to determine the functional significance of CHSY1 on cell 
adhesion, migration, proliferation and cell cycle. #326 siRNA was transfected into 
human palatal fibroblast using the established conditions and cell activities assay were 
performed subsequently.  
 
4.3.3.1.  The effect of knocking down CHSY1 on cell adhesion  
Cells were trypsinized 48 hours after transfection with #326 siRNA or negative 
siRNA and then reseeded into 24-well plates. MTS assay was performed at 8 hours 
after seeding. Compared to the control group, the RNAi group of CRL-1486 exhibited 





















Figure 4.3.3 The effect of blocking down CHSY1 on cell adhesion 
 
 
4.3.3.2.  The effect of blocking down CHSY1 on cell proliferation and cell cycle 
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4.3.3.2.1 The effect of blocking down CHSY1 on cell proliferation 
MTS assay was performed 4 days after transfection with #326 siRNA or negative 
siRNA. The proliferation of RNAi group was slower than the control group at 4 days 






















Figure 4.3.4  The effect of blocking down CHSY1 on cell proliferation 
 
4.3.3.2.2  The effect of blocking down CHSY1 on cell cycle 
DNA content distribution of a typical exponentially growing cell population is 
composed of two peaks of G1/G0 and G2/M phase and a valley of S phase. G2/M 
phase cells have twice the amount of DNA of G1/G0 phase cells, and S phase cells 
possess varying amounts of DNA between G1 and G2 cells. 
 
DNA content per cell had been the most significant cellular parameter to monitor 
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the cell proliferation since many decades. Flow cytometry was used to indicate the 
phase of cells in the cell cycle.  
Ethanol was used to fix the cells and permeabilize the membrane, which allows 
the dye (Propidium Iodide) to enter the cells. Propidium Iodide (PI) is a DNA-binding 
fluorochrome that intercalates in the double-helix. Ribonuclease-A is used to 
eliminate the staining of double-stranded RNA. 
The results showed that more cells (24%) were arrested in G2/M phase after 
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4.3.3.3. The effect of blocking down CHSY1 cell migration 
Figure 4.3.6 shows that the wound edges in the negative control group were 
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Figure 4.3.6 The effect of blocking down CSHY1 on cell migration 
 
   In summary, the results prove that CS affected human palatal fibroblast cell 
adhesion, proliferation, migration and cell cycle. This finding is similar to that from a 
previous study on C. elegans (Mizuguchi S, et al., 2003). It might illustrate the 
essentiality of the highly expressed CS and related genes in the wound tissues and 
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4.4 Study on the function of CS on 3-D palatal fibroblast culture model (Stage 4).  
 
4.4.1   3-D palatal fibroblast culture model 
 
In stage1, stage 2, and stage3 of this study, monolayer cell culture model was 
used to investigate the relationship between CS and palatal wound healing. 
However, cells cultured in monolayer are not in a physiological state. In vivo, cells 
are surrounded with extracellular matrix which is known to provide substrates for 
cell adhesion and cell migration, and to regulate cellular differentiation and 
metabolic function (Colige AC, 1992). Collagen is the major protein comprising 
the extracellular matrix. So in this study, Bell’s model which consists of cultured 
cells in a collagen gel was chosen to study the functional aspects of fibroblasts 
(Bell E, et al. 1981). This method allows the study of cell contractile properties in 
an in vivo-like environment.  
Cells were seeded into Vitrogen Collagen solutions mixed with or without 
chlorate, C-4-S, C-6-S. The cell-collagen solution was successfully formed into 
cell-gel composition.  Figure 4.4.1 shows the healthy spindle shape of fibroblasts 
in collagen gel after gelling. It suggests that fibroblasts could grow well in gel and 
the 3-D cell culture model was set up successfully. 
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30 minutes after gelling (40x) 
 
12 hours after gelling (40x) 
 
72 hours after gelling(40x) 
Figure 4.4.1 Cell morphology after gelling 
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4.4.2   Function of CS in 3-D palatal fibroblast culture model 
 
The contraction rate of cell-gel composite was quantitatively evaluated by the 
rest percentage of gels by Image J software. 
Fibroblast-gel contraction was observed as early as 24 hours after cell 
seeding and became apparent at 72 hours after cell seeding. As shown in Figure 
4.4.2, starting with same size gel, chlorate treated gel-cell contracted 66.4% after 
72 hours gelling, while only 39.4% contraction rate was observed in the control 
group (p<0.05). Furthermore, with addition of exogenous C-6-S in chlorate treated 
gel-cell, the contraction rate was slowed down at 46.2%, but 65.3% contraction 
rate was observed in the group with addition of exogenous C-4-S. These results 
suggested that the fibroblast-collagen gel contraction was promoted by the 
addition of chlorate. C-6-S could partially reduce the chlorate-promoted cell-gel 
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Figure 4.4.2 Cell-gel contraction under different conditions 
 
 
Interestingly, it was observed that exogenous C-6-S could inhibit the cell-gel 
contraction as long as 72 hours after gelling, while C-4-S exhibited the same 
contractile capability with 35.6% contraction rate compared with 39.4% contraction 
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Figure 4.4.3 Cell-gel contraction after addition of CS 
In summary, the cell-gel contraction was promoted by inhibition of CS sulfation 
and inhibited by the addition of exogenous C-6-S. Following the previous 3 stages of 
experiments, these findings of stage 4 further prove that CS may regulate palatal 
wound healing or wound contraction. It will be promising to improve wound healing 
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4.5  Study on the expression of CS during palatal wound healing (Stage 5) 
 
4.5.1   Histology of soft tissue wound healing in the rabbit palate 
 
H&E stainings were used to verify the wound site in every section selected from 
every tissue block (days 1, 3, 5, 7, 14, 21, 30 and 60). Wounds at different time point 
were evaluated for their histological features. 
At one day postsurgery, the wound defect has no epithelium left. At three days 
postsurgery, a blood clot and many polymorphonuclear leukocytes were observed in 
the wounds (Figure 4.5.1).  
   
 
 
1 day 100x 3 day 100x 
Wound bed Interface Wound bed
    Figure 4.5.1  Palatal wound wealing at one and three days postsurgery (H&E) 
 
At 5 and 7 days postsurgey, the wounds were filled with granulation tissue that 
was rich in fibroblasts, granulocytes, and an extracellular matrix without clear 
organization. (Figure 4.5.2).       
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5 day 100x 7 day  100x 
Figure 4.5.2  Palatal wound wealing at five and seven days postsurgery (H&E) 
 
At 14 and 21 days postsurgery, the wounds were covered with several epithelial 
cell layers (Figure 4.5.3). The wound was completely filled with granulation tissue 
that was rich in fibroblasts, granulocytes, some small blood vessels, and fibrous tissue. 
The inflammatory infiltrate was still present (labeled with arrow), although it was 
reduced compared to three days postsurgery.  
  
14 day   100X 21 day   100x 
Wound bed 
Wound bed 
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At 30days postsurgery, the epithelium had become thicker in the wounds and a 
cornified layer had formed (Figure 4.5.4). The inflammatory infiltrate had decreased. 
The number of fibroblasts had also decreased. At 60 days postsurgery, the histology is 
similar to that of normal tissue. 
 
 
30 day  100x 60 day  100x 
Figure 4.5.4 Palatal wound wealing at thirty and sixty days postsurgery (H&E) 
 
4.5.2 Immunohistochemistry (IHC) staining of CS56 
 
In both wounded and control mucosa, immunoreactivity for CS56 could be seen 
along the basement membrane or the underlying stroma. There was no specific 
immunostaining throughout the epithelium (Figure 4.5.5—4.5.7). No reaction was 
seen incubated with the secondary antibody alone.  
Changes in the pattern for CS56 immunoreactivity were observed at the wound 
bed and wound site basement membrane (BM). Because of the multi-step of washing 
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in the imuno-staining, the wound defect of day-one specimen had little tissue left. At 
the available earliest time point of day 3 after wounding, an increased 
immunoreaction for CS56 could be seen in the stroma of wound bed (labeled with 
arrows). At day 5 after wounding, the CS staining at wound bed was still observed, 
while the CS staining of the wound site basement membrane was absent (see Figure 
4.5.5). 
           
  
3 day   40x 5 day   100x 
BM 
BM 
Figure 4.5.5  Palatal wound wealing at three and five days postsurgery 
 
At day 14, with the occurrence of re-epithelialization around the wound site, 
there was still no immunoreactivity in the basement membrane of new epithelium. 
While at day 21, the immunostaining of wound site basement membrane was 
increased. But at both of day 14 and day 21, the CS staining of wound bed was 
strong.(Figure 4.5.6.) 
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Figure 4.5.6 Palatal wound wealing at Fourteen and Twenty-one days postsurgery 
 
At day 30 and day 60, the CS staining of wound site basement membrane 
increased and reached the same level as that of the normal epithelium. The staining at 
wound bed was still rich at day 30 and decreased to normal at day 60 (Figure 4.5.7). 
  




Figure 4.5.7  Palatal wound wealing at thirty and sixty days postsurgery 
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In summary, the expression of CS at wound bed was increased at early healing 
stage and then decreased to the normal level on day 60 after operation, while the 
expression at the wound site basement membrane was deceased at early time point 
and returned to normal at late time points.  
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Chapter V Discussion 
5.1. Study on the roles of CS and its sulfate group (Stage 1) 
   CS assists the formation of a collagen framework and associates with HA. 
Recent advances in research on the metabolism of CSPGs provide the basis for 
exciting new research questions. Controlling and directing the synthesis of CS 
chains to accelerate the migratory phase during which granulation tissue occurs is a 
practical goal. However, careful study of the biological function of GAG chains, 
especially CS, is required before clinical progress can be made in wound healing 
(Kosir , 2000). In this stage, the present author has examined the roles of CS and its 
sulfate group in palatal fibroblast adhesion, proliferation, and migration. Inhibition 
of chondroitin sulfation slows the wound-closure process in vitro. Both 
chondroitin-4-sulfate and chondroitin-6- sulfate are involved in promoting cell 
proliferation, an activity that is dependent on the presence of the sulfate group. 
However, the two CS species have antagonistic effects on cell adhesion: 
Chondroitin-6-sulfate increases whereas chondroitin-4-sulfate reduces it. 
 
5.1.1. Chondroitin sulfate and cell adhesion 
In this study, CS affected palatal fibroblast adhesion depending on their 
specific sulfate pattern. Generally, adhesion of fibroblast cells in granulation tissue 
is a fundamental process in wound healing (Hehenberger et al., 1998). Integrins are 
a family of transmembrane heterodimeric proteins that are important in cell-cell and 
cell-extracellular matrix adhesion (Hynes, 1992). Integrin-mediated cell adhesion 
results in localization of focal adhesion kinase (FAK), a cytoplasmic protein 
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tyrosine kinase, at focal adhesion points and the tyrosine phosphorylation of FAK 
(LaFlamme et al., 1996; Schaller, 2001). A CS binding site has recently been 
reported in α4β1 integrin (Iida et al., 1998). CS is required for α4β1 
integrin-mediated cell adhesion, and enhances FAK phosphorylation (Yang et al., 
2004). This integrin-mediated cell adhesion is inhibited after degradation of CS 
(Iida et al., 1992). These researches partially illustrated the mechanism of CS 
function on cell adhesion. However, more work is needed to illustrate the 
mechanism of every particular CS function on cell adhesion. 
 
5.1.2. Chondroitin sulfate and cell proliferation 
The FGF family consists of 22 members and is involved in regulating cell 
proliferation (Ornitz and Itoh, 2001). Binding of FGFs to their receptors results in 
dimerization and mutual tyrosine phosphorylation of these receptors, and is 
potentiated by heparan sulfate, a sulfated glycosaminoglycan (Bernfield et al., 
1999). FGF-2 has been shown to stimulate proliferation of gingival fibroblasts in 
vitro (Fujisawa et al., 2003). Myofibroblasts in full-thickness palatal mucoperiosteal 
wounds express FGF receptors-1 and -2 (Kanda et al., 2003). Furthermore, topical 
application of FGF-2 results in faster healing of gingival ulcers in rabbits (Fujisawa 
et al., 2003). Although the role of other sulfated glycosaminoglycans in FGF 
signaling has been less extensively investigated relative to heparan sulfate, recent 
studies suggest that CS and dermatan sulfate are also able to bind to FGF-2 and help 
mediate FGF-2-induced cell proliferation (Milev et al., 1998; Penc et al., 1998). 
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5.1.3. Chondroitin sulfate and cell migration 
Migration is a fundamental process involved in angiogenesis, granulation 
tissue formation and re-epithelialization. In this study, the results showed that the 
inhibition of CS sulfation impeded cell migration, whereas addition of exogenous 
CS could partially recover the inhibition. This result is consistent with a previous 
study which reported that CS proteoglycan enhanced cell spreading and migration 
by activating FAK and inhibiting RhoA activity (Yang et al., 2004). FAK has been 
shown to facilitate cell spreading and cell migration by down-regulating RhoA 
activity (Ren et al., 2000; Arthur et al., 2001; Wakatsuki et al., 2003). RhoA is a 
member of the Rho family of GTPases. Activation of RhoA results in formation of 
focal adhesions and stress fibers. Although some degree of RhoA activity is needed 
for cell adhesion to the substrate, a high RhoA activity level inhibits cell migration 
(Arthur et al., 2001).  
 
5.1.4. Limitation of this migration model 
Pure cell migration, involving spreading and motility, is preferably examined 
over a limited assay period to exclude the effect of the test agent or condition on 
cell proliferation. However, in this study, the monolayer wound healing model has 
not completely excluded the effect of cell proliferation on cell defect closure. 
Woodley et al. (Woodley DT, 1988) have developed a system, based on the work by 
Albrecht-Buehler, which fulfills this criterion (Albrecht-Buehler G. 1977). In this 
system keratinocytes are seeded at low cell densities on gold-coated glass coverslips 
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and incubated for 8 20 hours. Owing to phagocytosis of the particulate gold salts, 
the migratory behavior of the keratinocytes can be monitored quantitatively by 
image analysis. 
 
5.1.5. Specific requirement for sulfate group in chondroitin sulfate 
In rats, the degree of glycosaminoglycan sulfation changes with age 
(Weinstein et al., 1992). We have shown that the inhibition of chondroitin sulfation 
results in reduced cell adhesion and cell proliferation and a slower rate of wound 
gap closure. This is consistent with the findings in U-937 leukemia cells, where the 
number of sulfate groups on CS (as measured by the charge density) regulates cell 
proliferation and differentiation (Volpi et al., 1993). The present author have further 
shown that, depending on the position of the sulfate group, CS can either increase 
or decrease cell adhesion. It is suggested that changes in the number and position of 
the sulfate groups affect binding of growth factors and other signaling molecules to 
CS. Although the mechanism of this interaction is not well-understood in CS, there 
is well established evidence that the sulfate group specifically regulates binding of 
signaling molecules with HS. For example, the biological responses of neural 
precursor cells to FGF-1 and FGF-2 differ, depending on the sulfation pattern of HS 
(Brickman et al., 1998). HS sulfation also affects sonic hedgehog signaling during 
neural tube closure in the mouse embryo (Yip et al., 2002).  
In conclusion, the present results showed that CS plays an important role in 
palatal wound healing by regulating cell adhesion, cell proliferation, and cell 
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migration. However, since chlorate inhibits sulfation of all glycosaminoglycans, we 
cannot exclude the possibility that heparan sulfate or other sulfated 
glycosaminoglycans may also be involved. Indeed, exogenous sulfate effectively 
abolishes the biological effects of chlorate on cell adhesion and proliferation, 
whereas supplementation by chondroitin-6-sulfate alone statistically improves, but 
does not fully restore to normal these cellular processes. A combination of 
differently-sulfated CS species might lead to better improvement in wound healing 
compared with that achieved with chondroitin-6-sulfate alone. 
 
 
5.2. Study on the expression of CSPGs, CHSYs and CHSTs in an in vitro wound 
model (Stage2) 
5.2.1 In vitro monolayer wound model 
One problem which has to be solved in order to study orfacing wound healing 
studies at present in studying GAGs involved in wound healing in the human is the 
launch of assays that reliably detect the core proteins of PGs as well as the 
carbohydrate chains and synthases of GAGs. The enzymes in the wound may well 
actively degrade PGs as part of wound healing; thus in this study the development 
of assays for the core proteins of PGs and sythases of GAGs measure only the 
synthesis and not additional modifications in in vitro wound model. It permited 
more accurate understanding of the expression of CSPGs during wound healing. 
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Commonly, wound closure is simulated in vitro by simply creating defects in cell 
monolayers. Denudation of a cell monolayer can be performed mechanically using 
plastic pipette tips (Cha D, 1996) The cell-free area is then re-populated by adjacent 
cells through the combined action of migration and proliferation (Calderon M, 
1996). In vitro systems are generally rapid, simple, and less costly and involve 
minimal ethical considerations compared with in vivo wound models. In addition, 
pharmacological agent at different concentrations can be investigated 
simultaneously without the inherent heterogeneity of in vivo models. Furthermore, 
in vitro models are appropriate for studying the mechanism of action of a compound, 
which is complicated in vivo. The ultimate test of a wound healing agent is, 
however, in a living animal. 
5.2.2. Expression of CSPGs , CHSYs and CHSTs 
CSPGs constitute a family of extracellular matrix molecules that consist 
primarily of several core proteins (Neurocan, brevican, versican, and aggrecan), 
each of which have varying degrees of associated chondroitin sulfate 
glycosaminoglycans (Yamaguchi et al., 2000). The synthesis of CSPG involve a 
number of enzymes such as CHSYs for biosynthesis of chondroitin chains and 
CHSTs for sulphation of chondroitin chains. The present study is the first to 
evaluate the expression of these core proteins and synthases in an in vitro wound 
healing model. The results show that there is a burst of expression at early time 
after wounding. The increase of CSPGs and CHSYs in this in vitro human cell 
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culture model are in agreement with the finding of increase of CS at the wound of 
rabbit model in the first stage of experiment. Also the increase in CSPGs has been 
observed in other tissue injuries. Production of the different types of CSPG 
molecules is increased following cortical injury (Fitch et al,.1997), fornix lesions 
(Stichel et al,.1999), nigrostriatal axotomy  (Moon et al,.2002 ), and after spinal 
cord injury (Fitch et al,.1997; Lemons et al,.1999; Pasterkamp et al,.2001; Plant et 
al,.2001)  
This increase in CSPGs, CHSYs and CHSTs may be initiated or related to  
wound cytokines. It has been found that significantly higher levels of IL-1, IL-6, 
tumor necrosis factor, and macrophage colony-stimulating factor were detected in 
wound fluid compared with basal serum levels in non-wounded mice (Ford et al,. 
1989). Also Sugawara T (2001) reported that the synthesis of IL-1 and IL-6 was 
increased in the in vitro wound model. Currently there is increasing evidence for a 
link between inflammation and glycosylation. Several studies have shown that IL-1 
increases the amount of GAG synthesised by glomerular cells (Kashihara et al,. 
1992, Martin et al,.1995, Tesch et al,.1997). Tjew SL found GlcNAc6ST-1 and -4 
transcripts in human peripheral blood monocytes and induced upon exposure to 
TNF-α (Tjew  et al,. 2005). TNF-α influences glycosylation and sulfation. It 
increases the expression of α2, 3-sialyltransferase, α1, 3-fucosyltransferases, 
galactose-3-O-sulfotransferase, and N-acetylglucosamine-6-O-sulfotransferase 
epitopes in human bronchial mucosa (Delmotte et al,. 2002). 
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5.2.3. Cell source for CSPGs study 
In the present study, fetal human palatal fibroblast were used for the CSPGs 
study. It is stable cell line and enables easy experiment action. But it may not be 
able to fully reflect the granulation tissue fibroblast from human palate. Currently 
no model specific for granulation tissue fibroblasts in the migratory or proliferative 
phase of mucosa wound healing is available. Schor et al. and Hakkinen et al. used 
gingival fibroblasts from the granulation tissue of mucosal wounds in the oral cavity. 
They noted that the gingival fibroblasts in granulation tissue share some similarities 
to fetal fibroblasts. However, gingival fibroblasts are myofibroblastic and also 
produce keratin sulfate, which is not usually found in granulation tissue (Schor et al,. 
1996; Hakkinen et al,.1996.). Bertolami and Bronson used lapine fibroblasts, 
comparing dermal fibroblasts with those from granulation tissue and mature scars 
(Bertolami, et al,.1990). They noted differences in GAG chain synthesis that may 
support the concept of distinct fibroblast subtypes or else changes in fibroblast 
properties due to the wound environment. Others have used murine 3T3 fibroblasts 
to investigate aspects of fibroblast function. Previous work demonstrated that 90% 
of PGs in 3T3 cells are CSPG with few free CS chains (Wightman et al,.1986). 
Human dermal fibroblasts (papillary and reticular) have been examined from young 
and older human subjects, with differences in expression of decorin by papillary 
and reticular fibroblasts (Schonherr et al,.1993). Thus, the source of fibroblasts and 
age of the donor may introduce variability in the results. 
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5.3. Study on the function of CS synthase-1 gene by RNAi (Stage 3) 
5.3.1. Reagents and critical parameters of RNAi technology in the present study: 
RNA interference (RNAi) is a technique for down-regulating the expression of 
a specific gene in living cells by introducing a double-stranded RNA with a 
homology to the gene of interest. The choice of a transfection agent for delivery of 
siRNA is critical for gene silencing experiments. Without efficient transfection, 
siRNA will fail to elicit a cellular response. So, optimization of procedure is 
required when different transfection methods are used.  
Different cell types may vary in their response to different transfection reagent. 
It is important to select the appropriate siPORT transfection reagent for CRL-1486 
used in the presnet study. The present author observed for cell viability under the 
light microscope 48 hours after transfection using two different reagents: siPORT 
NeoFXTM and siPORT Amine. The results showed that a large number of cells died 
due to siPORT Amine (data not shown), while most cells grew well under siPORT 
NeoFXTM. So, siPORT NeoFXTM was chosen to be the appropriate agent for 
CRL-1486. 
Also, the volume of transfection agent used is a critical parameter that need to 
be optimized; too little can limit transfection, but too much can be toxic. Low 
transfection efficiency and low cell viability are the most frequent causes of 
unsuccessful gene silencing experiments. So a series of concentration of siPORT 
NeoFXTM was tested on CRL-1486.  
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5.3.2. Functions of chondroitin  
In the present study, knocking down of chondroitin expression resulted in 
inhibition of palatal fibroblast proliferation, adhesion and migration. Also more 
cells were arrested in G2/M phase. This result is the first to exhibit the function of 
chondroitin on mammalian cells. It is similar to that of previous studies which 
reported the novel functions of chondroitin in the morphogenesis and cell division 
of C. elegans, as revealed by RNAi experiments (Mizuguchi et al,. 2003) of the 
chondroitin synthase gene ( Kitagawa et al,.2001) . They reported that blocking of 
chondroitin synthesis resulted in cytokinesis defects in early embryogenesis. 
Reversion of cytokinesis was often observed in chondroitin-depleted embryos, and 
cell division eventually stops, resulting in early embryonic death. Their findings 
show that chondroitin is required for cell division. In consistent with their finding, 
the present data further implicated that CS is involved in human cell division and 
prolifertion. 
Chondroitin synthase (CHSY) is an enzyme involved in chondroitin sulfate 
synthesis. CHSY transferrs not only glucuronic acid (GlcUA) but also 
N-acetylgalactosamine (GalNAc) to the polymer chondroitin, to procduce the 
product named as GlcUA transferase (GlcAT) and GalNAc transferase (GalNAcT) 
respectively. GlcAT and GalNAcT are responsible for chondroitin sulfate 
biosynthesis (Kitagawa et al,. 2001).  
It has been reported that knocking down the expression of CHSY1 caused an 
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increase in the number of apoptotic cells (Yin et al,. 2005). CHSY1 has two 
identified functional domains: a galactosyl-transferase domain and a Fringe-like 
domain. Fringe regulation of Notch signaling is well characterized in Drosophila 
(Baron et al,. 2002; Panin et al,. 1998). Fringe regulates both the Notch1 and 
Notch2 pathways, inhibiting Notch1 signaling from Serrate/Jagged ligands while 
potentiating Notch2 signaling from Delta ligands (Fleming et al,.1997; Panin et al,. 
1997). Notch receptors interact with their cell-surface ligands, thereby affecting 
decisions of cell fate and survival (Jundt et al,. 2004). In all, it seems that CHSY1 
regulate cell proliferation by affecting cell cycle phases or through the Notch 
pathway.  
 
5.4. Study on the function of extraneous CS in 3-D multicelular model (Stage 4) 
5.4.1. In vitro 3-D multicellullar model: 
Cells cultured in 3D matrices commonly composed of type I collagen are used 
as in vitro wound healing model. Presumably 3D systems are more representative of 
normal wound physiology than two-dimensional systems (Eckes et al,.1995; 
Grinnell et al,.1994 ).Moreover, composition of the gel can be modified by 
incorporating different types of collagen and fibronectin to mimic the early 
granulation tissue deposited during wound repair more closely (Xu et al,. 1996). 3D 
fibroblast-populated collagen lattices lend themselves for studies on regulation and 
mechanisms of wound contraction( Eckes et al,.1995). It was found, for example 
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that conditioned medium from cultured macrophages stimulated contraction of such 
gels ( Ghassemifar et al,.1995).  
The fibroblast-populated collagen matrix (FPCM) is still not the perfect model 
for such a complex biological system as granulation tissue; for instance, the FPCM 
contains just one cell type, whereas granulation tissue contains many. In the clinical 
realm, the FPCM model was not able to predict responders vs. nonresponders among 
pressure ulcer patients treated with granulocyte/macrophage-colony stimulating 
factor and fibroblast growth factor-2 (Kuhn et al,.2000). Despite these and other 
inconsistencies, however, the FPCM has been utilized as a model of healing and 
granulation tissue in numerous original articles (Ehrlich et al,.1996; Grinnell et al,. 
1994; Cukierman et al,. 2002). 
5.4.2. CS on collagen gel contraction 
The collagen matrix-remodeling process has been used to mimic the matrix 
morphogenesis during development and wound repair (Bell et al,. 1979; Harris et 
al,.1981; Grinnell, 1994; Tomasek et al,.2002). Most of the experiments used 
purified collagen type I or mixtures of type I and type III preparations. A little 
information is available for other extracellular matrix components (Kubota et al., 
1988; Grant DS et al., 1989). The present author has demonstrated that CS 
efficiently inhibited contraction of collagen gels by human palatal fibroblasts. The 
results suggest that CS can suppress contractile activity of palatal fibroblasts. 
Fibroblasts display large traction effects and distort their substrates (Harris et 
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al., 1981; Fray et al., 1998). Traction force of cultured fibroblasts can wrinkle 
rubber substrates (Harris et al., 1980) or condense collagen matrix around the body 
of the cell (Yamato et al., 1995). With fibroblasts cultured in in collagen matrix, a 
loose collagen gel tethered at its edges can be pulled into tension (Bellows et al., 
1981; Eastwood et al., 1994). Harris AK and colleagues (1981) embedded two 
tissue explants more than a millimeter apart in a collagen gel and showed that after 
2–4 d, traction by the explant fibroblasts had combined to produce a ligament-like 
strap on the axis between the explants. All these data implied that there is some 
driving force behind the patterning of collagen in connective tissues during 
development and wound healing (Bellows et al., 1982; Stopak and Harris, 1982). 
PGs or GAGs can modulate activity of cytokines/growth factors (Ruoslahti 
and Yamaguchi, 1991) and seem to bind to cells via specific binding sites on a 
variety of cells and transformed cell lines (Leung et al., 1989; Halper, 1990; 
Bradbury and Parish, 1991). This function of PGs and GAGs may modulate the 
cellular phenotype and behaviour in the 3-D culture environment. A previous study 
reported that heparin and heparan sulfate can inhibit gel contraction (Guidry C and 
Grinnell F, 1987). Schaefer T found that human umbilical vein endothelial cells 
contracted collagen I/III gels far less efficiently than human dermal fibroblasts and 
the addition of heparan sulfate and heparin almost completely inhibited contraction. 
It suggested that GAGs participate in cell-matrix interactions by effectively 
modulating the cellular phenotype, and it is a different cell type specific response 
(Schaefer T, 1996). 
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Although the mechanisms underlying it remain to be determined, CS appears 
to be useful for correcting aberrant activation status of palatal fibroblasts and may 
have therapeutic potential for the treatment of palatal wounds. 
 
5.5. Study on the expression of CS during palatal wound healing of rabbit 
model (Stage 5) 
 
5.5.1. Histology of palatal wound healing in rabbit model 
The wounds in our study showed that palatal wound healing in rabbit model 
comprises a dynamic process of inflammation, matrix formation, neo-angiogenesis 
and re-epithelialization and various cell types are engaged in this process, which is 
in agreement with others (Glat et al,. 1997;Hakkinen et al,. 2000). Oral mucosa 
defects are often an inevitable consequence of maxillofacial surgery. The surface 
area of these wounds is reduced by the proliferation and migration of cells as well 
as by wound contraction and scarring. When wound contraction and scar tissue 
formation occur during skeletal growth, it counteracts normal development of the 
facial skeleton. Histological studies have shown that the tissue that develops by 
wound healing on the palatal bone after palatal repair in animal models is different 
from normal palatal mucosa. It lacks elastic fibers, the collagen fibers are oriented 
in a transverse direction, and the tissue is attached to the underlining bone by 
Sharpey's fibers (Wijdeveld et al,.1991; Cornelissen et al,.2000). It has been shown 
that the collagen fibers in a healing wound tend to run in the direction of the 
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contraction forces (Machesney et al,. 1998). Squier and Kremenak (1980) have 
shown that myofibroblasts are present in healing palatal wounds of the beagle dog 
from 7 days postsurgery, and are most numerous between 10 and 15 days.  
 
5.5.2. Expression of CS during rabbit palatal wound healing 
It would be expected that cells in proliferative granulation tissue would 
synthesize and secrete a greater amount of protein (such as the ECM components 
described previously) compared to cells in relatively quiescent scar tissue. CS 
staining was used to evaluate the formation of granular tissue in an in vivo model of 
normal rabbit palatal mucosa wound healing. The result shows that the expression 
of CS at wound bed is increased at early healing stage and then decrease to the 
normal level expressed in ECM near wound bed, while the expression at the wound 
site basement membrane was deceased at early time points and increased to normal 
at late time points. It suggests that chondroitin sulfate is involved in rabbit mucosa 
wound healing. This is in agreement with previous studies. Over-expression of CS 
was detected in dermal tissue early in normal wound healing (Loots MA 1998). The 
granulation tissue of healing skin wounds and scars stained intensely for CSPG and 
weakly or not at all for decorin (Yeo TK, et al., 1991). CS-labeling has been proven 
to be one of the discriminative markers for basement membarane regeneration after 
injury of full-thickness skin in a porcine wound model (Lamme EN, 1996). The 
phenomenon of up-regulated CSPGs is also found at the early stage of other wound 
healing. A high concentration of CSPGs has been found near the lesion center of 
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spinal cord injury (Davies, et al., 1999; Lemons ML, et al., 1999) and brain injury 
(Gilbert RJ, 2005; Asher RA et al., 2002; Levine JM 1994).  
CS is more characteristic of cells that are not forming attachments (Lark MW 
and Culp LA 1987). A population of fibroblasts that shows more CS chains favors 
movement and proliferation (Clark RAF 1988; Martin P. 1997; Laterra J. 1980; 
Couchman JR and Hook M. 1988). So, in this in vivo wound healing model, a 
rapidly increased CS56 at early time point suggested that fibroblasts which are 
localized in the exposed wound area may start to synthesize proteoglycans in the 
early phase and this may result in the migration of more fibroblasts to the wound 
site resulting in fibroblast proliferation.  
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5.6. Conclusions 
    This present study carried out a series of 5 experiments to investigate the 
biological function of CS and its relationship with palatal wound healing. In the stage 
1 experiment, we examined the roles of CS and its sulfate group in human palatal 
fibroblast adhesion, proliferation, and migration. Inhibition of chondroitin sulfation 
slowed the wound-closure process in vitro. Both chondroitin-4-sulfate and 
chondroitin-6- sulfate are involved in promoting cell proliferation, an activity that is 
dependent on the presence of the sulfate group. However, the two CS species have 
antagonistic effects on cell adhesion: Chondroitin-6-sulfate increases but 
chondroitin-4-sulfate reduces adhesion. Stage 2 experiments illustrated that CSPGs 
and CHSYs had a burst expression at early time after wound in the human cell culture 
model. In the stage 3 experiment, knocking down of chondroitin expression by RNAi 
technique resulted in inhibition of palatal fibroblast proliferation, adhesion and 
migration. Also more cells were arrested in G2/M phase. This result is the first that 
exhibit the function of chondroitin in mammalian cells. In the stage 4 experiment, 
extraneous CS efficiently inhibited contraction of collagen gels by human palatal 
fibroblasts. The results suggested that CS can suppress contractile activity of palatal 
fibroblasts. Stage 5 experiment of in vivo palatal healing showed that the expression of 
CS56 (chondroitin sulfate containing proteoglycans) in the stroma of wound bed 
increased at early healing stage. 
In all, these sequential experiments on in vivo and in vitro wound models proved 
that CS and CSPGs are involved in palatal wound healing; chondroitin and chondroitin 
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sulfation affect palatal fibroblast cell cycle, proliferation, adhesion and migration; and 
extraneous CS inhibits contraction of collagen gels by human palatal fibroblasts. These 
findings provide a biological basis for future application of CS for palatal wound 
healing. Of course, before clinical application, further studies are still needed to focus 
on these active molecules and their correct dosage, timing, sequence of administration, 
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Congenital cleft palate is one of the most common birth defects, having anincidence of 1.5 to 2 per 1000 births (Mitchell and Wood, 2000). Timely
surgical correction is a mainstay of treatment. Critical events for wound
healing after surgical closure of cleft palate are cell proliferation, cell
adhesion, and cell migration. However, the molecular regulation of palatal
wound healing is not well-understood. Recent studies have implicated
fibroblast growth factor-2 (FGF-2) and transforming growth factor-1 in
palatal wound healing (Yokozeki et al., 1997; Kanda et al., 2003). In
addition, interferon-gamma has been shown to modulate collagen
production and the formation of scar tissue in post-surgical palatal wound
healing (Cornelissen et al., 2000). A common feature among these is the
involvement of chondroitin sulfate (CS) proteoglycans (Hakkinen et al.,
1996; Milev et al., 1998; Hurt-Camejo et al., 1999). In this study, we
investigated the function of CS in cell proliferation, cell adhesion, and cell
migration during palatal wound healing.
CS is a glycosaminoglycan, composed of alternating, differently-sulfated
residues of -D-glucuronate and -D-N-acetylgalactosamine residues (Murata
and Yokoyama, 1985). It can be found within intracellular organelles, on the
cell surface, and in the extracellular matrix (Hook et al., 1984). CS has been
implicated in the wound-healing process. Fibroblasts derived from granulation
tissue, compared with normal gingival fibroblasts, have highly elevated
expression levels of versican, a CS proteoglycan (Hakkinen et al., 1996). CS
and other sulfated glycosaminoglycans are found in high concentrations in
human wound fluid (Penc et al., 1998). Furthermore, injection of glycyl-
histidyl-lysine-Cu2+, an activator of wound healing, into full-thickness rat skin
wounds results in accumulation of CS and stimulates wound tissue production
(Simeon et al., 2000). Together, these studies suggest that CS may be
involved in regulating the wound-healing process.
The aim of this study was to examine the roles of CS in palatal wound
healing, with the rabbit as a model organism. We investigated the effects of
CS on palatal fibroblast proliferation, adhesion, and migration. We also
determined if the position of the sulfate group on CS modulates its
biological action.
MATERIALS & METHODS
Isolation and Primary Culture of Rabbit Palatal Fibroblasts
All animal experiments were approved by the Ethics Committee, Faculty of
Dentistry, National University of Singapore. Soft palatal mucosa was harvested
from adult New Zealand white rabbits, weighing between 2.8 and 3 kg, with the use
of a Number 18 blade under sterile conditions. The mucosa was washed thrice with
0.9% sodium chloride solution containing 200 units/mL penicillin and 200 g/mL
streptomycin. After removal of the overlying epithelium, the remaining tissues were
cut into small pieces and incubated at 37°C for 2.5 hrs in 0.9% sodium chloride,
0.25% collagenase type I, and 0.2% albumin. The palatal fibroblasts were pelleted
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by centrifugation at 250 g for 10 min, and washed 3 times with
culture medium consisting of Dulbecco's modified Eagle's Medium,
10% fetal calf serum, 100 units/mL penicillin, and 100 g/mL
streptomycin. The cells were then re-suspended in culture medium
supplemented with chlorate, sulfate, bovine trachea chondroitin-4-
sulfate, shark cartilage chondroitin-6-sulfate, or chondroitinase ABC
(all from Sigma, St. Louis, MO, USA), and cultured at 37°C in a
humidified atmosphere with 5% CO2. The culture medium was
changed every 3 days. All in vitro assays were carried out with
passage 2 cells derived from at least 3 independent animals.
Assessment of cultured cells was performed with the use of an
Olympus 1X70 inverted microscope (Olympus, Hamburg, Germany).
Cell Adhesion Assay
The palatal fibroblasts were seeded into 24-well plates at a density
of 60,000 cells/well and cultured for 8 hrs. The number of
fibroblasts adhering to the culture plate was then determined by the
CellTiter 96® AQ
ueous
Non-Radioactive Cell Proliferation Assay
(Promega, Madison, WI, USA). Briefly, the tetrazolium compound
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) was incubated with cultured
cells for 1 hr, during which metabolically active cells converted the
MTS reagent to a soluble formazan dye. The amount of
absorbance, which is proportional to the number of living cells in
culture, was then measured at 490 nm.
Cell Proliferation Assay
Cells were seeded into 24-well plates at a density of 30,000
cells/well and cultured for 7 days. The number of fibroblasts after
culture was measured at Day 7 by the CellTiter 96® AQ
ueous
Non-
Radioactive Cell Proliferation Assay as described above.
In vitro Wound Closure Model
Cells were grown in six-well plates until they achieved 90%
confluence. Using a 100-L plastic pipette tip, we scraped 3
horizontal lines across the bottom of each well ('wounding'). The
distance between the wound edges was then determined at 0 and 18
hrs after wounding, as a measure of cell migration (Guo et al., 2003).
Scanning Electron Microscopy
Palatal fibroblasts were cultured on glass slides to 90% confluence,
and were then wounded as described above. After culture
continued for 18 hrs, the cells were fixed in 3% glutaraldehyde and
2% paraformaldehyde in 0.1 mol/L cacodylate for 30 min,
followed by 2% osmium tetroxide. The cells were then dehydrated
in increasing concentrations of methanol, transferred to acetone,
and dried in a Balzers critical-point dryer with liquefied carbon
dioxide as the transition fluid. Cells were coated with 20 nm gold
by means of a Balzers sputter-coater and examined with a Philips
XL-30 field-emission-gun scanning electron microscope.
Statistical Analysis
Cell proliferation, cell adhesion, and in vitro wound healing were
compared among treatment groups by Student's t test or one-way
analysis of variance with Tukey's post-test or test for linear trend,
with the use of GraphPad Prism v4.01 for Windows (GraphPad
Software, San Diego, CA, USA).
RESULTS
Chondroitin Sulfate Regulates Palatal Fibroblast
Adhesion and Proliferation
To determine if CS is involved in regulating palatal fibroblast
adhesion, we cultured fibroblasts in the presence of
chondroitinase ABC, an enzyme that breaks down CS.
Degradation of endogenous CS resulted in a significant
reduction in the number of adherent cells (Fig. 1A), suggesting
Figure 1. Chondroitin sulfate regulates palatal fibroblast adhesion and
proliferation. (A) Degradation of chondroitin sulfate by the addition of 0.1
unit/mL chondroitinase ABC to the culture medium for 8 hrs results in a
decrease in the number of adherent cells (Student's t test; p = 0.0076). (B)
Conversely, supplementation of the culture medium with chondroitin-6-
sulfate for the same time period leads to a dose-dependent increase in cell
adhesion (one-way ANOVA; p < 0.0001). (C) In the cell proliferation
assay, statistical comparison by one-way ANOVA shows that palatal
fibroblasts cultured in the presence of chondroitin-6-sulfate over a seven-
day period show a dose-dependent increase in cell numbers (p <
0.0001). Values represent mean ± SEM of 3 experiments.
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that CS is needed for cell adhesion. Furthermore, culture
medium supplementation with 1000 ng/mL or less of
exogenous chondroitin-6-sulfate led to a dose-dependent
increase in cell adhesion (Fig. 1B). Post-test for linear trend
yielded a coefficient of determination (r2) of 0.9321 (p <
0.0001).
We also studied the effect of exogenous chondroitin-6-
sulfate on cell proliferation, as measured by the number of
metabolically active cells after a seven-day culture period (Fig.
1C). At a concentration of up to 1000 ng/mL, there was a
statistically significant dose-dependent increase in cell numbers
(r2 = 0.9840; p < 0.0001), showing that chondroitin-6-sulfate is
involved in regulating cell proliferation.
Requirement for Sulfate Group for Biological Activity 
of Chondroitin Sulfate
Chlorate is an inhibitor of glycosaminoglycan sulfation, and
has been used in cell, organ, and whole embryo cultures to
inhibit sulfation with no significant effect on
glycosaminoglycan or protein synthesis or on cell viability
(Conrad, 1998; Yip et al., 2002). It acts by competing with
sulfate in synthesis of 3-phosphoadenosine 5-phosphosulfate,
the sulfate donor for glycosaminoglycan sulfation. We have
previously shown that 30 mmol/L chlorate is sufficient to
abolish chondroitin sulfation completely (Yip et al., 2002).
To determine if the sulfate group of CS is necessary for the
biological activity of the molecule, we studied the effects on
cell adhesion and cell proliferation of palatal fibroblasts
treated with 30 mmol/L chlorate. Cells exposed to chlorate
appeared healthy and had the same spindle-shaped
morphology as those in the control group cultured in chlorate-
free medium. However, there was a significant reduction in
adhesion (Figs. 2A, 2B) and proliferation (Fig. 2C) of
chlorate-treated cells. The reduction was due to competitive
inhibition of glycosaminoglycan sulfation, and was abolished
by the addition of 10 mmol/L exogenous sulfate to culture
medium containing chlorate (Fig. 2A). Furthermore,
supplementation of chlorate-containing culture medium with
exogenous chondroitin-6-sulfate resulted in an increase in cell
adhesion (Fig. 2B) and cell proliferation (Fig. 2C), as
compared with cells exposed to chlorate alone. Together, these
results show that the sulfate group is needed for the biological
activity of CS.
Effect of Chondroitin Sulfate on Cell Migration 
and Wound Closure in vitro
To determine the effect of CS on cell migration and wound
closure, we used an in vitro wound closure model where
'wounding' was achieved by horizontal scraping across the
bottoms of wells containing 90% confluent palatal fibroblasts
(Guo et al., 2003). We determined the rate of wound closure
by measuring the distance between the wound edges 18 hrs
after wounding occurred (Fig. 3A). Starting with an average
wound gap of 489 m, the distance decreased by 92.7% after
18 hrs (Fig. 3B). In contrast, the rate of wound closure was
dramatically slower in the chlorate-treated group, with only
39.9% reduction in wound gap distance 18 hrs after
wounding occurred. This shows that glycosaminoglycans are
involved in cell  migration and wound closure.  The
requirement for CS in this process is further supported by the
finding that wound closure in the presence of chlorate and
exogenous chondroitin-6-sulfate was significantly more rapid
than in samples cultured in the presence of chlorate alone
(Fig. 3B).
Figure 2. The sulfate group is required for biological effects of
chondroitin sulfate. Palatal fibroblasts were cultured for 8 hrs in normal
culture medium, medium supplemented with 30 mmol/L chlorate, or
medium with 30 mmol/L chlorate plus (A) 10 mmol/L sulfate or (B) 100
ng/mL chondroitin-6-sulfate (C6S). The number of adherent cells varied
among treatment groups (one-way ANOVA; p < 0.0001), with fewer
adherent cells in the chlorate-alone-treated group compared with the
control group (Tukey's test; p < 0.001 in both panels). Fibroblasts treated
with chlorate plus exogenous sulfate or chondroitin-6-sulfate showed
significantly greater adhesion than those treated with chlorate alone (p <
0.001 in each case). (C) In the cell proliferation assay, continuous
chlorate treatment also led to reduced cell numbers after a seven-day
culture period (p < 0.001). This reduction was significantly blocked by
the addition of 100 ng/mL chondroitin-6-sulfate to the culture medium (p
< 0.001). Values represent mean ± SEM of 3 experiments.
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Biological Effect of Sulfate Group Position 
in Chondroitin Sulfate
To determine if the position of the sulfate group in CS
influences its biological action, we examined the effect of
treatment with exogenous chondroitin-4-sulfate on cell
adhesion and cell proliferation of palatal fibroblasts. As in the
chondroitin-6-sulfate experiment (Fig. 1C), treatment with
chondroitin-4-sulfate resulted in a dose-dependent increase in
cell proliferation (Fig. 4B). However, unlike chondroitin-6-
sulfate, which increased the number of adherent cells (Fig. 1B),
exposure to a concentration of up to 1000 ng/mL chondroitin-4-
sulfate led to a dose-dependent reduction in cell adhesion (Fig.
4A; post-test for linear trend; r2 = 0.8282; p = 0.0017). These
findings suggest that the sulfate group position in CS
specifically determines its biological function.
DISCUSSION
We have examined the roles of CS and its sulfate group in
palatal fibroblast adhesion, proliferation, and migration.
Inhibition of chondroitin sulfation slows the wound-closure
process in vitro. Both chondroitin-4-sulfate and chondroitin-6-
sulfate are involved in promoting cell proliferation, an activity
that is dependent on the presence of the sulfate group.
However, the two CS species have antagonistic effects on cell
adhesion: Chondroitin-6-sulfate increases but chondroitin-4-
sulfate reduces adhesion.
Chondroitin Sulfate and Cell Adhesion
Adhesion of fibroblast cells in granulation tissue is a
fundamental process in wound healing (Hehenberger et al.,
1998). Integrins are a family of transmembrane heterodimeric
proteins that are important in cell-cell and cell-extracellular
matrix adhesion (Hynes, 1992). Integrin-mediated cell adhesion
results in localization of focal adhesion kinase (FAK), a
cytoplasmic protein tyrosine kinase, at focal adhesion points
Figure 3. Chondroitin sulfate regulates cell migration and wound
closure in vitro. (A) Scanning electron micrograph of palatal fibroblasts
cultured for 18 hrs in the presence of 30 mmol/L chlorate, after the
making of a linear wound as described in MATERIALS & METHODS.
The distance between the wound edges is indicated (*). (B) Statistical
comparison of the distance between wound edges 18 hrs after
wounding occurred shows a significant difference (one-way ANOVA; p
< 0.001) among cel ls cul tured in normal medium, medium
supplemented with 30 mmol/L chlorate, or medium with 30 mmol/L
chlorate plus 100 ng/mL chondroitin-6-sulfate (C6S). The wound gap in
the chlorate-alone-treated group was significantly wider compared with
that in the control group (Tukey's test; p < 0.001) or with the group
treated with chlorate plus chondroitin-6-sulfate (p < 0.001). Values
represent mean ± SEM of 9 wounds per group.
Figure 4. Biological effects of chondroitin-4-sulfate. (A) Palatal
fibroblasts cultured for 8 hrs in medium supplemented with chondroitin-
4-sulfate showed a dose-dependent reduction in cell adhesion (one-way
ANOVA; p = 0.0049). (B) In the cell proliferation assay, statistical
comparison shows that continuous supplementation of the culture
medium with chondroitin-4-sulfate led to a dose-dependent increase in
cell numbers after a seven-day culture period (p = 0.0074). Values
represent mean ± SEM of 3 experiments.
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and the tyrosine phosphorylation of FAK (LaFlamme and Auer,
1996; Schaller, 2001). A CS binding site has recently been
reported in 41 integrin (Iida et al., 1998). CS is required for
41 integrin-mediated cell adhesion, and enhances FAK
phosphorylation (Yang et al., 2004). This integrin-mediated
cell adhesion is inhibited after degradation of CS (Iida et al.,
1992).
Chondroitin Sulfate and Cell Proliferation
The FGF family consists of 22 members and is involved in
regulating cell proliferation (Ornitz and Itoh, 2001). Binding of
FGFs to their receptors results in dimerization and mutual
tyrosine phosphorylation of these receptors, and is potentiated
by heparan sulfate, a sulfated glycosaminoglycan (Bernfield et
al., 1999). FGF-2 has been shown to stimulate proliferation of
gingival fibroblasts in vitro (Fujisawa et al., 2003).
Myofibroblasts in full-thickness palatal mucoperiosteal wounds
express FGF receptors-1 and -2 (Kanda et al., 2003).
Furthermore, topical application of FGF-2 results in faster
healing of gingival ulcers in rabbits (Fujisawa et al., 2003).
Although the role of other sulfated glycosaminoglycans in FGF
signaling has been less extensively investigated relative to
heparan sulfate, recent studies suggest that CS and dermatan
sulfate are also able to bind to FGF-2 and help mediate FGF-2-
induced cell proliferation (Milev et al., 1998; Penc et al.,
1998).
Chondroitin Sulfate and Cell Migration
In addition to its role in cell adhesion, discussed above, FAK
has been shown to facilitate cell spreading and cell migration
by down-regulating RhoA activity (Ren et al., 2000; Arthur and
Burridge, 2001; Wakatsuki et al., 2003). RhoA is a member of
the Rho family of GTPases. Activation of RhoA results in
formation of focal adhesions and stress fibers. Although some
degree of RhoA activity is needed for cell adhesion to the
substrate, a high RhoA activity level inhibits cell migration
(Arthur and Burridge, 2001). Indeed, it has been suggested that
melanoma CS proteoglycan enhances cell spreading and
migration by activating FAK and inhibiting RhoA activity
(Yang et al., 2004).
Specific Requirement for Sulfate Group 
in Chondroitin Sulfate
In rats, the degree of glycosaminoglycan sulfation changes with
age (Weinstein et al., 1992). We have shown that the inhibition
of chondroitin sulfation results in reduced cell adhesion and
cell proliferation and a slower rate of wound gap closure. This
is consistent with the findings in U-937 leukemia cells, where
the number of sulfate groups on CS (as measured by the charge
density) regulates cell proliferation and differentiation (Volpi et
al., 1993). We have further shown that, depending on the
position of the sulfate group, CS can either increase or decrease
cell adhesion. We suggest that changes in the number and
position of the sulfate groups affect binding of growth factors
and other signaling molecules to CS. Although the mechanism
of this interaction is not well-understood in CS, there is well-
established evidence that the sulfate group specifically
regulates binding of signaling molecules with heparan sulfate.
For example, the biological responses of neural precursor cells
to FGF-1 and FGF-2 differ, depending on the sulfation pattern
of heparan sulfate (Brickman et al., 1998). Heparan sulfation
also affects sonic hedgehog signaling during neural tube
closure in the mouse embryo (Yip et al., 2002).
In conclusion, we have shown that CS plays an important
role in palatal wound healing by regulating cell adhesion, cell
proliferation, and cell migration. However, since chlorate
inhibits sulfation of all glycosaminoglycans, we cannot exclude
the possibility that heparan sulfate or other sulfated
glycosaminoglycans may also be involved. Indeed, exogenous
sulfate effectively abolishes the biological effects of chlorate
on cell adhesion and proliferation, whereas supplementation by
chondroitin-6-sulfate alone statistically improves, but does not
fully restore to normal, these cellular processes. A combination
of differently-sulfated CS species might lead to better
improvement in wound healing compared with that achieved
with chondroitin-6-sulfate alone. Studies are currently under
way in our laboratory to determine this, as well as the possible
involvement of other sulfated glycosaminoglycans in wound
healing.
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